{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 90,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Loading database from 250719...\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "c:\\Users\\jyh23\\miniforge3\\envs\\dev3.12\\Lib\\site-packages\\scipy\\stats\\_stats_py.py:240: RuntimeWarning: invalid value encountered in log\n",
      "  log_a = xp.log(a)\n"
     ]
    }
   ],
   "source": [
    "import os\n",
    "import math\n",
    "import datetime\n",
    "import string\n",
    "import time\n",
    "import random\n",
    "import datetime\n",
    "from glob import glob\n",
    "import importlib\n",
    "import random\n",
    "\n",
    "import numpy as np\n",
    "from scipy.stats import gmean\n",
    "import pandas as pd\n",
    "import yfinance as yf\n",
    "import yahooquery as yq\n",
    "\n",
    "from utils import *\n",
    "import fundamental.analysis\n",
    "\n",
    "importlib.reload(fundamental.analysis)\n",
    "\n",
    "# db = fundamental.analysis.Database(\"DB/usa/250531\")\n",
    "# db = fundamental.analysis.Database(\"DB/usa/250524\")\n",
    "db = fundamental.analysis.Database()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [],
   "source": [
    "def get_upside_potential(value_summary):\n",
    "    \"\"\"\n",
    "    Calculate the upside potential of a stock based on its fair price.\n",
    "    \"\"\"\n",
    "    period = \"(This Year)\"  # \"(This Year)\", \"(Next Year)\"\n",
    "\n",
    "    upside_potential = (value_summary[f\"Forward PEGR Fair Price {period}\"] / value_summary[\"Price\"]) - 1\n",
    "    value_summary[\"Upside Potential\"] = upside_potential\n",
    "    return value_summary"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "Ticker",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "Sector",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "Industry",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "Long Business Summary",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "Market Cap",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "Price",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "Forward PER Fair Price (This Year)",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "Forward PEGR Fair Price (This Year)",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "Upside Potential",
         "rawType": "float64",
         "type": "float"
        }
       ],
       "ref": "4da91f3f-8a8d-4e54-8d4f-cbce6731e90b",
       "rows": [
        [
         "A",
         "Healthcare",
         "Diagnostics & Research",
         "Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. This segment also offers GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies. The Diagnostics and Genomics segment provides genomics, contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses; and cell analysis plate based assays, flow cytometers, real-time cell analyzers, cell imaging systems, microplate readers, and related consumables. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.",
         "33053794304.0",
         "113.98999786376953",
         "99.45459877628983",
         "163.7131846912223",
         "0.4362065774128481"
        ],
        [
         "AA",
         "Basic Materials",
         "Aluminum",
         "Alcoa Corporation, together with its subsidiaries, engages in the bauxite mining, alumina refining, aluminum production, and energy generation business in Australia, Brazil, Canada, Iceland, Norway, Spain, the United States, and internationally. The company operates through two segments, Alumina and Aluminum. It operates bauxite and other aluminous ores mining; and processes bauxite into alumina for sale to aluminum smelter customers and customers who process it into industrial chemical products through supply contracts to third parties, as well as aluminum smelting and casting businesses. The company offers primary aluminum in the form of alloy ingot or value-add ingot to customers that produce products for transportation, building and construction, packaging, wire, other industrial markets, and traders. In addition, it provides energy that generates and sells electricity in the wholesale market to traders, large industrial consumers, distribution companies, and other generation companies. The company was formerly known as Alcoa Upstream Corporation and changed its name to Alcoa Corporation in October 2016. The company was founded in 1886 and is headquartered in Pittsburgh, Pennsylvania.",
         "7852497408.0",
         "30.329999923706055",
         "53.930343267355646",
         "392.33130179059367",
         "11.935420467441078"
        ],
        [
         "AACB",
         "Financial Services",
         "Shell Companies",
         "Artius II Acquisition Inc. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intend to focus on technology enabled businesses that offer technology software and services, or financial services. The company was incorporated in 2024 and is based in New York, New York.",
         "297233984.0",
         "10.109999656677246",
         "0.0",
         null,
         null
        ],
        [
         "AACBU",
         "Financial Services",
         "Shell Companies",
         "Artius II Acquisition Inc. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intend to focus on technology enabled businesses that offer technology software and services, or financial services. The company was incorporated in 2024 and is based in New York, New York.",
         "266855008.0",
         "10.600000381469727",
         "0.0",
         null,
         null
        ],
        [
         "AACG",
         "Consumer Defensive",
         "Education & Training Services",
         "ATA Creativity Global, together with its subsidiaries, provides educational services in China and internationally. The company offers portfolio training services, research-based learning services, overseas study counselling services, in-school art classes through cooperation with high schools and training organizations, junior art education, and other educational services to students. It also provides online courses for students. The company provides its services through partnership with sales channels, internet and mobile advertisement, word of mouth referral, and marketing events and activities. The company was formerly known as ATA Inc. and changed its name to ATA Creativity Global in September 2019. ATA Creativity Global was founded in 1999 and is based in Hefei, China.",
         "25932090.0",
         "0.8199999928474426",
         "0.0",
         null,
         null
        ],
        [
         "AACT",
         "Financial Services",
         "Shell Companies",
         "Ares Acquisition Corporation II does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in New York, New York.",
         "702726144.0",
         "11.359999656677246",
         "0.0",
         null,
         null
        ],
        [
         "AAL",
         "Industrials",
         "Airlines",
         "American Airlines Group Inc., through its subsidiaries, operates as a network air carrier in the United States, Latin America, Atlantic, and Pacific. The company provides scheduled air transportation services for passengers and cargo through its hubs in Charlotte, Chicago, Dallas/Fort Worth, Los Angeles, Miami, New York, Philadelphia, Phoenix, and Washington, D.C., as well as through partner gateways in London, Doha, Madrid, Seattle/Tacoma, Sydney, and Tokyo. It also operates a mainline fleet of 977 aircraft. The company was formerly known as AMR Corporation and changed its name to American Airlines Group Inc. in December 2013. American Airlines Group Inc. was founded in 1926 and is headquartered in Fort Worth, Texas.",
         "8250495488.0",
         "12.510000228881836",
         "18.644864734251108",
         "46.99918472613978",
         "2.7569291659669815"
        ],
        [
         "AAM",
         "Financial Services",
         "Shell Companies",
         "AA Mission Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. AA Mission Acquisition Corp. was incorporated in 2024 and is based in The Woodlands, Texas.",
         "459528288.0",
         "10.449999809265137",
         "0.0",
         null,
         null
        ],
        [
         "AAME",
         "Financial Services",
         "Insurance - Life",
         "Atlantic American Corporation, through its subsidiaries, provides life and health, and property and casualty insurance products in the United States. It operates through American Southern and Bankers Fidelity segments. The company offers property and casualty insurance products, including commercial automobile insurance coverage for state governments, local municipalities, and other motor pools and fleets; general liability insurance; and inland marine insurance products. It also provides surety bond coverage for subdivision construction; school bus contracts; and performance and payment bonds. In addition, the company offers individual and group whole life insurance products; Medicare supplement insurance products; other accident and health insurance products comprising various individual and group policies for the payment of standard benefits for the treatment of cancer and other critical illnesses; Vantage Flex Plus, a hospital indemnity plan; and Vantage Recovery short-term care product and a group whole life product. It markets its products through independent agents and brokers. The company was founded in 1937 and is based in Atlanta, Georgia. Atlantic American Corporation operates as a subsidiary of Atlantic American / Delta Group.",
         "44363908.0",
         "2.1700000762939453",
         "0.0",
         null,
         null
        ],
        [
         "AAMI",
         "Financial Services",
         "Asset Management",
         "BrightSphere Investment Group Inc. is a publically owned asset management holding company. The firm provides its services to individuals and institutions. It manages separate client focused portfolios through its subsidiaries. The firm also launches equity mutual funds for its clients. It invests in public equity, fixed income, and alternative investment markets through its subsidiaries. The firm was founded in 1980 is based Boston, Massachusetts. It was formally known as BrightSphere Investment Group plc. BrightSphere Investment Group Inc. was formed in 1980 and is based in Boston, Massachusetts.",
         "1433959808.0",
         "40.060001373291016",
         "31.202909994172753",
         "103.80995472692562",
         "1.5913617366008945"
        ],
        [
         "AAOI",
         "Technology",
         "Communication Equipment",
         "Applied Optoelectronics, Inc. designs, manufactures, and sells fiber-optic networking products in the United States, Taiwan, and China. It offers optical modules, optical filters, lasers, laser components, subassemblies, transmitters and transceivers, turn-key equipment, headend, node, and distribution equipment, as well as amplifiers. The company sells its products to internet data center operators, cable television, telecom equipment manufacturers, fiber-to-the-home, and internet service providers through its direct and indirect sales channels. Applied Optoelectronics, Inc. was incorporated in 1997 and is headquartered in Sugar Land, Texas.",
         "1607262336.0",
         "28.6299991607666",
         "0.9455757530378956",
         "867624.44397354",
         "30303.731729175095"
        ],
        [
         "AAON",
         "Industrials",
         "Building Products & Equipment",
         "AAON, Inc., together with its subsidiaries, engages in engineering, manufacturing, marketing, and selling air conditioning and heating equipment in the United States and Canada. The company operates through three segments: AAON Oklahoma, AAON Coil Products, and BASX. It offers rooftop units, data center cooling solutions, cleanroom systems, chillers, packaged outdoor mechanical rooms, air handling units, makeup air units, energy recovery units, condensing units, geothermal/water-source heat pumps, coils, and controls. The company markets and sells its products to retail, manufacturing, educational, lodging, supermarket, data centers, medical and pharmaceutical, and other commercial industries. It sells its products through a network of independent manufacturer representative organizations and internal sales force, as well as online. AAON, Inc. was incorporated in 1987 and is headquartered in Tulsa, Oklahoma.",
         "6402698240.0",
         "78.69000244140625",
         "42.48687382892917",
         "1119.698597779411",
         "13.229235773796747"
        ],
        [
         "AAP",
         "Consumer Cyclical",
         "Auto Parts",
         "Advance Auto Parts, Inc. engages in the provision of automotive aftermarket parts in the United States and internationally. The company offers batteries and battery accessories; belts and hoses; brakes and brake pads; chassis parts; climate control parts; clutches and drive shafts; engines and engine parts; exhaust systems and parts; hub assemblies; ignition components and wire; radiators and cooling parts; starters and alternators; and steering and alignment parts. It also provides air conditioning chemicals and accessories; air fresheners; antifreeze and washer fluid; electrical wire and fuses; electronics; floor mats, seat covers and interior accessories; hand and specialty tools; lighting; performance parts; sealants, adhesives and compounds; tire repair accessories; vent shades, mirrors and exterior accessories; washes, waxes and cleaning supplies; and wiper blades. In addition, the company offers air filters; fuel and oil additives; fuel filters; grease and lubricants; motor oil; oil filters; part cleaners and treatments; and transmission fluid. Further, it provides battery and wiper installation; engine light scanning and checking; electrical system testing, including batteries, starters, and alternators; oil and battery recycling; and loaner tool program services. The company serves professional installers and do-it-yourself customers. It operates stores under the Advance Auto Parts and Carquest names. The company has stores in the United States, Puerto Rico, the U.S. Virgin Islands, and Canada; and independently owned Carquest branded stores in Mexico and the Caribbean Islands. Advance Auto Parts, Inc. was founded in 1929 and is based in Raleigh, North Carolina.",
         "3663251968.0",
         "61.130001068115234",
         "30.500352989278745",
         "13428.007469004018",
         "218.66313159460952"
        ],
        [
         "AAPG",
         "Healthcare",
         "Biotechnology",
         "Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company's primary product candidate is HQP1351, a BCR-ABL inhibitor targeting BCR-ABL1 mutants, including those with the T315I mutation. It also develops APG-2575, an oral administered Bcl-2 selective inhibitor for hematologic malignancies and solid tumors; APG-115, an oral small molecule inhibitor of the MDM2-p53 protein-protein interactions to treat solid tumors and hematological malignancies; and APG-1252, a small molecule drug to restore apoptosis through dual inhibition of the Bcl-2 and Bcl-xL proteins for the treatment of small-cell lung cancer, non-small cell lung cancer, neuroendocrine tumor, and non-Hodgkin's lymphoma. In addition, the company is developing APG-1387, a small-molecule inhibitor of apoptosis proteins for advanced solid tumors and chronic HBV infection; APG-2449, an oral inhibitor of FAK, ROS1, and ALK kinases; APG-5918, an orally available and selective embryonic ectoderm development inhibitor. In addition, it is also involved in medical research and development; clinical development; clinical trials operations; venture capital investment; rental of buildings; and science and technology promotion services. The company has collaboration relationships with biotechnology and pharmaceutical companies; and research institutions. Ascentage Pharma Group International was founded in 2009 and is headquartered in Suzhou, China.",
         "3740606720.0",
         "40.38999938964844",
         "-45.81813859093326",
         null,
         null
        ],
        [
         "AAPL",
         "Technology",
         "Consumer Electronics",
         "Apple Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide. The company offers iPhone, a line of smartphones; Mac, a line of personal computers; iPad, a line of multi-purpose tablets; and wearables, home, and accessories comprising AirPods, Apple TV, Apple Watch, Beats products, and HomePod. It also provides AppleCare support and cloud services; and operates various platforms, including the App Store that allow customers to discover and download applications and digital content, such as books, music, video, games, and podcasts, as well as advertising services include third-party licensing arrangements and its own advertising platforms. In addition, the company offers various subscription-based services, such as Apple Arcade, a game subscription service; Apple Fitness+, a personalized fitness service; Apple Music, which offers users a curated listening experience with on-demand radio stations; Apple News+, a subscription news and magazine service; Apple TV+, which offers exclusive original content; Apple Card, a co-branded credit card; and Apple Pay, a cashless payment service, as well as licenses its intellectual property. The company serves consumers, and small and mid-sized businesses; and the education, enterprise, and government markets. It distributes third-party applications for its products through the App Store. The company also sells its products through its retail and online stores, and direct sales force; and third-party cellular network carriers, wholesalers, retailers, and resellers. Apple Inc. was founded in 1976 and is headquartered in Cupertino, California.",
         "3154142035968.0",
         "211.17999267578125",
         "169.5871201558405",
         "672.3080789443597",
         "2.183578474578961"
        ],
        [
         "AARD",
         "Healthcare",
         "Biotechnology",
         "Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Its lead product candidate is ARD-101, an oral gut-restricted small-molecule agonist of certain targeting bitter taste receptors expressed in the gut lumen, which is in the Phase 3 clinical trial for hyperphagia associated with Prader-Willi Syndrome, as well as in the Phase 2 clinical trial for hyperphagia associated with acquired hypothalamic obesity resultant from the treatment of craniopharyngioma, including surgery or radiation. The company is also developing ARD-201, which is in the Phase 1 clinical trial for the treatment of obesity. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.",
         "252016880.0",
         "11.619999885559082",
         "-47.60094553999681",
         "-113.36415029351814",
         "-10.75595106798607"
        ],
        [
         "AAT",
         "Real Estate",
         "REIT - Diversified",
         "American Assets Trust, Inc. is a full service, vertically integrated and self-administered real estate investment trust (\"REIT\"), headquartered in San Diego, California. The company has over 55 years of experience in acquiring, improving, developing and managing premier office, retail, and residential properties throughout the United States in some of the nation's most dynamic, high-barrier-to-entry markets primarily in Southern California, Northern California, Washington, Oregon, Texas and Hawaii. The company's office portfolio comprises approximately 4.1 million rentable square feet, and its retail portfolio comprises approximately 2.4 million rentable square feet. In addition, the company owns one mixed-use property (including approximately 94,000 rentable square feet of retail space and a 369-room all-suite hotel) and 2,302 multifamily units. In 2011, the company was formed to succeed to the real estate business of American Assets, Inc., a privately held corporation founded in 1967 and, as such, has significant experience, long-standing relationships and extensive knowledge of its core markets, submarkets and asset classes.",
         "1557150336.0",
         "20.139999389648438",
         "0.0",
         null,
         null
        ],
        [
         "AAUC",
         "Basic Materials",
         "Gold",
         "Allied Gold Corporation, together with its subsidiaries, explores and produces mineral deposits in Africa. The company primarily explores for gold and silver ores. Its flagship project is the Sadiola gold project, an open pit mine located in the Republic of Mali. The company holds interest in the Bonikro and Hiré mines located in Côte d'Ivoire; the Agbaou mine located in Côte d'Ivoire; and the Kurmuk gold project located in Ethiopia. The company was formerly known as Allied Gold Corp Limited & Allied Merger Corporation and changed its name to Allied Gold Corporation in September 2023. Allied Gold Corporation is based in Toronto, Canada.",
         "1559924096.0",
         "13.520000457763672",
         "0.0",
         null,
         null
        ],
        [
         "AB",
         "Financial Services",
         "Asset Management",
         "AllianceBernstein Holding L.P. is a publicly owned investment manager. The firm is a related adviser The firm manages separate client focused portfolios for its clients. The firm primarily invests in common and preferred stocks, warrants and convertible securities, government and corporate fxed-income securities, commodities, currencies, real estate-related assets and infation-protected securities. The firm employs quantitative analysis along with long-term purchases, short-term purchases, trading, short sales, margin transactions, option strategies including writing covered options, uncovered options and spread strategies to make its investments. The firm obtains external research to complement its in-house research. The firm was formerly known as Alliance Capital Management Holding LP. AllianceBernstein Holding L.P. was founded in 1967 and is based in Nashville,Tennessee.",
         "4561947136.0",
         "41.209999084472656",
         "35.04636573330616",
         "48.27234971193937",
         "0.17137468537648437"
        ],
        [
         "ABAT",
         "Basic Materials",
         "Other Industrial Metals & Mining",
         "American Battery Technology Company operates as a battery materials company in the United States. The company explores for resources of battery metals, such as lithium, nickel, cobalt, and manganese; and develops and commercializes technologies for the extraction and refining of battery metals. It also commercializes an integrated process for the recycling of lithium-ion batteries. The company was formerly known as American Battery Metals Corporation and changed its name to American Battery Technology Company in August 2021. American Battery Technology Company was incorporated in 2011 and is headquartered in Reno, Nevada.",
         "222057376.0",
         "2.4000000953674316",
         "0.0",
         null,
         null
        ],
        [
         "ABBV",
         "Healthcare",
         "Drug Manufacturers - General",
         "AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, generalized pustular psoriasis, and pyoderma gangrenosum; Skyrizi to treat autoimmune diseases, erythrodermic psoriasis, generalized pustular psoriasis, and palmoplantar pustulosis; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta/Venclyxto to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic to treat neurologic diseases; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duopa and Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; and Qulipta for episodic and chronic migraine, as well as other neuroscience products. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.",
         "334308868096.0",
         "189.25999450683594",
         "218.16262119899147",
         "306.533009312084",
         "0.6196397453716096"
        ],
        [
         "ABCB",
         "Financial Services",
         "Banks - Regional",
         "Ameris Bancorp operates as the bank holding company for Ameris Bank that provides range of banking services to retail and commercial customers. It operates through four segments: Banking Division, Retail Mortgage Division, Warehouse Lending Division, and Premium Finance Division. The company offers commercial and retail checking, regular interest-bearing savings, money market, individual retirement, and certificates of deposit accounts. It also provides commercial real estate, residential real estate mortgage, agricultural, and commercial and industrial loans; consumer loans, including motor vehicle, home improvement, and home equity loans, as well as loans secured by savings accounts and personal credit lines. In addition, the company originates, administers, and services commercial insurance premium loans, equipment finance loans, and small business administration loans. Further, it operates full-service domestic banking offices, and mortgage and loan production offices. The company was founded in 1971 and is headquartered in Atlanta, Georgia.",
         "4640459264.0",
         "67.33999633789062",
         "59.99934405507525",
         "87.28440632154089",
         "0.29617480053868084"
        ],
        [
         "ABCL",
         "Healthcare",
         "Biotechnology",
         "AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.",
         "1337212800.0",
         "4.480000019073486",
         "-11.499104821459904",
         null,
         null
        ],
        [
         "ABEO",
         "Healthcare",
         "Biotechnology",
         "Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is pz-cel, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio.",
         "339168864.0",
         "6.590000152587891",
         "-8.200911965692335",
         "-1014.251613273743",
         "-154.90767675103115"
        ],
        [
         "ABEV",
         "Consumer Defensive",
         "Beverages - Brewers",
         "Ambev S.A., through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, malt and food, other alcoholic beverages, and non-alcoholic and non-carbonated products in Brazil, Central America and Caribbean, Latin America South, and Canada. It offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Budweiser, Bud Light, Beck, Leffe, Hoegaarden, Balboa ICE, Balboa, Atlas Golden Light, Atlas, Bucanero, Cristal, Mayabe, Presidente, Presidente Light, Brahma Light, Bohemia, The One, Corona, Modelo Especial, Stella Artois, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Michelob Ultra, Busch, Pilsen, Ouro Fino, Bud 66, Banks, Deputy, Patricia, Labatt Blue, Alexander Keith's, and Kokanee brands. The company also provides carbonated soft drinks, bottled water, isotonic beverages, energy drinks, coconut water, powdered and natural juices, and ready-to-drink teas under the Guaraná Antarctica, Gatorade, H2OH!, Pepsi Black, Lipton Iced Tea, Fusion, Pepsi-Cola, Canada Dry, Squirt, Red Rock, Red Bull, Seven Up, Nutrl, Bud Light Seltzer, Palm Bay, and Mike's brands. It offers its products through a network of third-party distributors and a direct distribution system. The company was founded in 1885 and is headquartered in São Paulo, Brazil. Ambev S.A. operates as a subsidiary of Interbrew International B.V.",
         "38382784512.0",
         "2.3499999046325684",
         "2.958708017094839",
         "266.111425568354",
         "112.23890909262039"
        ],
        [
         "ABG",
         "Consumer Cyclical",
         "Auto & Truck Dealerships",
         "Asbury Automotive Group, Inc., together with its subsidiaries, operates as an automotive retailer in the United States. It operates through Dealerships and Total Care Auto, Powered by Landcar (TCA) segments. The company offers a range of automotive products and services, including new and used vehicles; and vehicle repair and maintenance services, replacement parts, collision repair, and recondition of used vehicle services. It also provides finance and insurance products, including arranging vehicle financing through third parties; and aftermarket products, such as extended vehicle service contracts, guaranteed asset protection debt cancellation, prepaid maintenance contracts, key replacement contracts, paintless debt repair contracts, appearance protection contracts, tire and wheel, and lease wear and tear contracts. The company sells its products and services to individual retail customers, other dealers, and licensed wholesalers through its network of dealerships and at auctions. Asbury Automotive Group, Inc. was founded in 1996 and is headquartered in Duluth, Georgia.",
         "4520829952.0",
         "229.9600067138672",
         "440.70863796327484",
         null,
         null
        ],
        [
         "ABL",
         "Financial Services",
         "Insurance - Life",
         "Abacus Global Management, Inc. operates as an alternative asset manager and market maker in the United States. It operates in five segments: Active Management, Originations, Asset Management, Portfolio Servicing, and Technology Services. The Active Management segment is involved in the buying, selling, and trading of policies; and the maintenance of policies until receipt of death benefits. Its Originations segment originates life insurance policy settlements between investors or buyers, and the sellers, who are often the original policy owners. The Asset Management segment provides asset management services to investors investing in alternative investment and equity portfolio funds based on fund investment agreements. Its Portfolio Servicing segment offers policy services to customers on a contract basis. The Technology Services segment provides real-time mortality verification, missing participant verification, and other services specific to the life insurance market services to customers on a contract basis. It sells its products through financial advisors or agents, direct-to-consumer, and traditional life settlements intermediaries. The company was formerly known as Abacus Life, Inc. and changed its name to Abacus Global Management, Inc. in February 2025. Abacus Global Management, Inc. was founded in 2004 and is headquartered in Orlando, Florida.",
         "495211072.0",
         "5.059999942779541",
         "8.497664946514767",
         "128.06473124836387",
         "24.309235710784577"
        ],
        [
         "ABLV",
         "Communication Services",
         "Advertising Agencies",
         "Able View Global Inc. operates as a brand management partners of beauty and personal care brands in China. It offers brand management services, such as strategy, branding, digital and social marketing, omni-channel sales, customer services, overseas logistics, and warehouse and fulfilment. The company was founded in 2022 and is headquartered in Shanghai, China.",
         "52353292.0",
         "1.059999942779541",
         "0.0",
         null,
         null
        ],
        [
         "ABLVW",
         "Communication Services",
         "Advertising Agencies",
         "Able View Global Inc. operates as a brand management partners of beauty and personal care brands in China. It offers brand management services, such as strategy, branding, digital and social marketing, omni-channel sales, customer services, overseas logistics, and warehouse and fulfilment. The company was founded in 2022 and is headquartered in Shanghai, China.",
         null,
         null,
         "0.0",
         null,
         null
        ],
        [
         "ABM",
         "Industrials",
         "Specialty Business Services",
         "ABM Industries Incorporated, through its subsidiaries, engages in the provision of integrated facility, infrastructure, and mobility solutions in the United States and internationally. It operates through Business & Industry, Manufacturing & Distribution, Education, Aviation, and Technical Solutions segments. The company offers janitorial, facilities engineering, and parking services for commercial real estate properties, including corporate offices for high tech clients, sports and entertainment venues, and traditional hospitals and non-acute healthcare facilities; and vehicle maintenance and other services to rental car providers. It also offers integrated facility services, engineering, and other specialized services in various types of manufacturing, distribution, and data center facilities. In addition, the company delivers custodial and landscaping and grounds for public school districts, private schools, colleges, and universities. Further, it supports airlines and airports with services comprising passenger assistance, catering logistics, air cabin maintenance, and transportation services. Additionally, the company provides facility infrastructure, mechanical and electrical services; and electric vehicle power and microgrid systems design, installation, and maintenance services. ABM Industries Incorporated was founded in 1909 and is headquartered in New York, New York.",
         "2970951936.0",
         "47.720001220703125",
         "78.01631379938183",
         "189.54846821361664",
         "2.972096885265414"
        ],
        [
         "ABNB",
         "Consumer Cyclical",
         "Travel Services",
         "Airbnb, Inc., together with its subsidiaries, operates a platform that enables hosts to offer stays and experiences to guests worldwide. Its marketplace connects hosts and guests online or through mobile devices to book spaces and experiences. It also offers gift cards. The company was formerly known as AirBed & Breakfast, Inc. and changed its name to Airbnb, Inc. in November 2010. Airbnb, Inc. was founded in 2007 and is headquartered in San Francisco, California.",
         "85977800704.0",
         "139.33999633789062",
         "69.0670545519294",
         "402.19367954108645",
         "1.8864194783369475"
        ],
        [
         "ABOS",
         "Healthcare",
         "Biotechnology",
         "Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate Sabirnetug (ACU193), a recombinant humanized immunoglobulin gamma 2, which has completed the INTERCEPT-AD phase 1 clinical trial and in ALTITUDE-AD phase 2 clinical trial to target soluble amyloid-beta oligomers. It has a collaboration and license agreement with Halozyme, Inc. for the development of a subcutaneous formulation of Sabirnetug. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Newton, Massachusetts.",
         "90860096.0",
         "1.5",
         "-35.182268894209926",
         null,
         null
        ],
        [
         "ABP",
         "Healthcare",
         "Biotechnology",
         "Abpro Holdings, Inc., a biotechnology company, focuses on novel antibody constructs for immuno-oncology and ophthalmology. Its platforms include DiversImmune, a discovery platform that generates a diverse collection of proprietary antibodies against clinically validated and novel targets; and MultiMab, an engineering platform that provides the flexibility to combine antibody building blocks in different combinations and orientations to create fit for purpose novel full-length multi-specific antibody constructs. The company's lead product candidates include ABP-102, a next generation immuno-oncology TetraBi antibody targeting HER2 and CD3 is developed for the treatment of HER2+ solid tumors, including breast and gastric cancers; and ABP-201, a TetraBi antibody format that simultaneously inhibit VEGF and ANG-2 for the treatment of vascular diseases of the eye, including diabetic macular edema and wet age-related macular degeneration. It also develops ABP-110, a TetraBi antibody targeting GPC3 and CD3 for the treatment of hepatocellular carcinoma; and ABP-150, a TetraBi antibody targeting claudin 18.2 and CD3 for the treatment of gastric cancers. The company has strategic partnership with Celltrion Inc. and Abpro Bio International, Inc. Abpro Holdings, Inc. was incorporated in 2004 and is headquartered in Woburn, Massachusetts.",
         "12394530.0",
         "0.20399999618530273",
         "0.0",
         null,
         null
        ],
        [
         "ABPWW",
         "Healthcare",
         "Biotechnology",
         "Abpro Holdings, Inc., a biotechnology company, focuses on novel antibody constructs for immuno-oncology and ophthalmology. Its platforms include DiversImmune, a discovery platform that generates a diverse collection of proprietary antibodies against clinically validated and novel targets; and MultiMab, an engineering platform that provides the flexibility to combine antibody building blocks in different combinations and orientations to create fit for purpose novel full-length multi-specific antibody constructs. The company's lead product candidates include ABP-102, a next generation immuno-oncology TetraBi antibody targeting HER2 and CD3 is developed for the treatment of HER2+ solid tumors, including breast and gastric cancers; and ABP-201, a TetraBi antibody format that simultaneously inhibit VEGF and ANG-2 for the treatment of vascular diseases of the eye, including diabetic macular edema and wet age-related macular degeneration. It also develops ABP-110, a TetraBi antibody targeting GPC3 and CD3 for the treatment of hepatocellular carcinoma; and ABP-150, a TetraBi antibody targeting claudin 18.2 and CD3 for the treatment of gastric cancers. The company has strategic partnership with Celltrion Inc. and Abpro Bio International, Inc. Abpro Holdings, Inc. was incorporated in 2004 and is headquartered in Woburn, Massachusetts.",
         null,
         null,
         "0.0",
         null,
         null
        ],
        [
         "ABR",
         "Real Estate",
         "REIT - Mortgage",
         "Arbor Realty Trust, Inc. invests in a diversified portfolio of structured finance assets in the multifamily, single-family rental, and commercial real estate markets in the United States. The company operates through Structured Business and Agency Business segments. It primarily invests in bridge and mezzanine loans, including junior participating interests in first mortgages, and preferred and direct equity, as well as real estate-related joint ventures, real estate-related notes, and various mortgage-related securities. In addition, the company offers bridge financing products to borrowers who seek short-term capital to be used in an acquisition of property; financing by making preferred equity investments in entities that directly or indirectly own real property; mezzanine financing in the form of loans that are subordinate to a conventional first mortgage loan and senior to the borrower's equity in a transaction; junior participation financing in the form of a junior participating interest in the senior debt; and financing products to borrowers who are looking to acquire conventional, workforce, and affordable single-family housing. Further, it underwrites, originates, sells, and services multifamily mortgage loans through conduit/commercial mortgage-backed securities programs. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was incorporated in 2003 and is headquartered in Uniondale, New York.",
         "2336769280.0",
         "11.210000038146973",
         "25.65807896042677",
         null,
         null
        ],
        [
         "ABSI",
         "Healthcare",
         "Biotechnology",
         "Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to design differentiated antibody therapeutics. Its preclinical development programs include ABS-101 for the treatment of inflammatory bowel disease; ABS-201 for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, and Owkin for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington.",
         "397984064.0",
         "3.119999885559082",
         "-14.16065731571688",
         "-72.75042745401056",
         "-24.317445552077064"
        ],
        [
         "ABT",
         "Healthcare",
         "Medical Devices",
         "Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company provides pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.",
         "215166009344.0",
         "123.66999816894531",
         "91.90726383812418",
         "280.3417392177344",
         "1.2668532656947256"
        ],
        [
         "ABTS",
         "Financial Services",
         "Capital Markets",
         "Abits Group Inc., through its subsidiary, operates in the bitcoin mining business in the United States. It also provides in-house support services. The company was formerly known as Moxian (BVI) Inc and changed its name to Abits Group Inc. in November 2023. Abits Group Inc. was incorporated in 2021 and is based in Causeway Bay, Hong Kong.",
         "11163359.0",
         "4.710000038146973",
         "0.0",
         null,
         null
        ],
        [
         "ABUS",
         "Healthcare",
         "Biotechnology",
         "Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States. Its chronic Hepatitis B virus product pipeline comprises Imdusiran, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic product candidate which is in phase 1 and phase 2a clinical trials that suppresses all HBV antigens, including HBsAg expression; and AB-101, an oral PD-L1 inhibitor, which is in phase 1a/1b clinical trial that has the potential to reawaken patients' HBV-specific immune response by inhibiting PD-L1. The company has licensing agreement with Alnylam Pharmaceuticals, Inc. to develop and commercialize products with LNP delivery technology. The company was formerly known as Tekmira Pharmaceuticals Corporation and changed its name to Arbutus Biopharma Corporation in July 2015. Arbutus Biopharma Corporation was incorporated in 2005 is headquartered in Warminster, Pennsylvania.",
         "599479552.0",
         "3.130000114440918",
         "-7.66606988097327",
         "-138.39931981015872",
         "-45.217033466428376"
        ],
        [
         "ABVC",
         "Healthcare",
         "Biotechnology",
         "ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials as a combination therapy for triple negative breast cancer; ABV-1504, which has completed Phase II clinical trials for depressive disorders; ABV-1505, which is in Phase II clinical trials for adult attention deficit hyperactivity disorder; ABV-1702, which is in Phase II clinical trials to treat myelodysplastic syndromes; and ABV-1601, which is in Phase I/II clinical trials for treating depression in cancer patients. It is also developing ABV-1701 Vitargus, which is in Phase II clinical trials for the treatment of retinal detachment or vitreous hemorrhage; and ABV-1519, which is in Phase I/II clinical trials for the treatment of non-small cell lung cancer; ABV-1703, which is in Phase II clinical trials for the treatment of metastatic pancreatic cancer. ABVC BioPharma, Inc. has a co-development agreement with Rgene Corporation and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is headquartered in Fremont, California. ABVC BioPharma, Inc. operates as a subsidiary of YuanGene Corporation.",
         "56888360.0",
         "3.3499999046325684",
         "0.0",
         null,
         null
        ],
        [
         "ABVE",
         "Consumer Defensive",
         "Packaged Foods",
         "Above Food Ingredients Inc., a regenerative ingredient company, produces vertically integrated supply chain products in Canada, the United States, Mexico, China, France, Turkey, and internationally. It operates through two segments: Disruptive Agriculture and Rudimentary Ingredients, and Consumer Packaged Goods. The Disruptive Agriculture and Rudimentary Ingredients segment engages in the provisioning of discrete genetics, origination, purchasing, grading, processing, and sale of regeneratively grown grain; and origination, purchase, and sale of bespoke ingredients products. The Consumer Packaged Goods segment formulates, manufactures, sells, distributes, and markets proprietary consumer product formulations in owned brands; and focuses on manufacturing and distribution for private-labeled retail owned brands. Above Food Ingredients Inc. is based in Regina, Canada.",
         "138217856.0",
         "2.700000047683716",
         "0.0",
         null,
         null
        ],
        [
         "ABVEW",
         "Consumer Defensive",
         "Packaged Foods",
         "Above Food Ingredients Inc., a regenerative ingredient company, produces vertically integrated supply chain products in Canada, the United States, Mexico, China, France, Turkey, and internationally. It operates through two segments: Disruptive Agriculture and Rudimentary Ingredients, and Consumer Packaged Goods. The Disruptive Agriculture and Rudimentary Ingredients segment engages in the provisioning of discrete genetics, origination, purchasing, grading, processing, and sale of regeneratively grown grain; and origination, purchase, and sale of bespoke ingredients products. The Consumer Packaged Goods segment formulates, manufactures, sells, distributes, and markets proprietary consumer product formulations in owned brands; and focuses on manufacturing and distribution for private-labeled retail owned brands. Above Food Ingredients Inc. is based in Regina, Canada.",
         null,
         "0.2750000059604645",
         "0.0",
         null,
         null
        ],
        [
         "ABVX",
         "Healthcare",
         "Biotechnology",
         "ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod that is in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis, as well as in Phase 2b clinical trial to treat patients with Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.",
         "641750144.0",
         "9.949999809265137",
         "-61.226047648215",
         "-10.320799932902307",
         "-2.0372663447985087"
        ],
        [
         "AC",
         "Financial Services",
         "Asset Management",
         "Associated Capital Group, Inc., together with its subsidiaries, provides investment advisory services in the United States. It offers alternative investment management services; operates a direct investment business; and invests in new and existing businesses. The company was founded in 1976 and is headquartered in Greenwich, Connecticut. Associated Capital Group, Inc. is a subsidiary of GGCP Holdings LLC.",
         "787379328.0",
         "37.25",
         "0.0",
         null,
         null
        ],
        [
         "ACA",
         "Industrials",
         "Engineering & Construction",
         "Arcosa, Inc., together with its subsidiaries, provides infrastructure-related products and solutions for the construction, engineered structures, and transportation markets in the United States. The company operates through three segments: Construction Products, Engineered Structures, and Transportation Products. The Construction Products segment offers natural and recycled aggregates; specialty materials; and construction site support equipment, including trench shields and shoring products for residential and non-residential construction, and specialty/other products, as well as for infrastructure construction. The Engineered Structures segment offers utility structures, wind towers, traffic and lighting structures, and telecommunication structures for electricity transmission and distribution, wind power generation, highway road construction, and wireless communication markets. This segment sells its products to contractors and distributors serving state Departments of Transportation and state and municipality agencies. The Transportation Products segment offers inland barges, fiberglass barge covers, winches, marine hardware, and other transportation and industrial equipment to the commercial marine transportation companies, lessors, and industrial shippers. Arcosa, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.",
         "4393448960.0",
         "90.0",
         "78.75337775271801",
         "1136.9191621170276",
         "11.63243513463364"
        ],
        [
         "ACAD",
         "Healthcare",
         "Biotechnology",
         "ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis; and DAYBUE, a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 for treatment of Rett Syndrome. It also develops Pimavanserin which completed Phase III clinical trial to treat the negative symptoms of schizophrenia; ACP-101, which completed phase III clinical trial for the treatment of hyperphagia in Prader-Willi syndrome; ACP-204 that completed phase II clinical trial for the treatment of Alzheimer's disease psychosis and Lewy Body Dementia with psychosis; ACP-711, which is in phase I clinical trial for the treatment of essential tremor; ACP-211 that is in phase I clinical trial for the treatment of treatment-resistant depression; ACP-2591 that is in Phase I development for Rett syndrome and Fragile X syndrome; and ACP-271, a GPR88 agonist used in evaluation of neurology and is in the IND-enabling stage. The company has a license agreement with Neuren Pharmaceuticals Limited to trofinetide for Rett syndrome and other indications; and a license and collaboration agreement with Stoke Therapeutics, Inc. to discover, develop and commercialize novel RNA-based medicines for the potential treatment of severe and rare genetic neurodevelopmental diseases of the CNS. The company was formerly known as Receptor Technologies, Inc. and changed its name ACADIA Pharmaceuticals Inc. in 1997. ACADIA Pharmaceuticals Inc. was incorporated in 1993 and is headquartered in San Diego, California.",
         "3775686656.0",
         "22.559999465942383",
         "9.462426162849704",
         null,
         null
        ],
        [
         "ACB",
         "Healthcare",
         "Drug Manufacturers - Specialty & Generic",
         "Aurora Cannabis Inc., together with its subsidiaries, engages in production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; sale of medical and consumer use cannabis products; and the propagation of vegetables and floral plants. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. The company was founded in 2013 and is headquartered in Edmonton, Canada.",
         "254796208.0",
         "4.53000020980835",
         "0.0",
         null,
         null
        ],
        [
         "ACCO",
         "Industrials",
         "Business Equipment & Supplies",
         "ACCO Brands Corporation designs, manufactures, and markets consumer, school, technology, and office products in the United States, Canada, Brazil, Mexico, Chile, Europe, the Middle East, Australia, New Zealand, and Asia. It operates in two segments, ACCO Brands Americas and ACCO Brands International. The company offers note taking products, computer and gaming accessories, planners, workspace machines, tools and essentials, and dry erase boards and accessories, as well as filing and organization products, and writing and art products; and shredding, laminating and binding machines, stapling, punching, and do-it-yourself tools. It sells its products under the Five Star, PowerA, Tilibra, AT-A-GLANCE, Kensington, Quartet, GBC, Mead, Swingline, Barrilito, Foroni, Hilroy, Leitz, Rapid, Esselte, Rexel, PowerA, NOBO, Franken, Derwent, Marbig, Artline, and Spirax brands. The company distributes its products through various channels, including mass retailers, e-tailers, discount, drug/grocery, and variety chains, warehouse clubs, hardware and specialty stores, independent office product dealers, office superstores, wholesalers, contract stationers, and technology specialty businesses, as well as sells products directly to commercial and consumer end-users through its e-commerce platform and direct sales organization. The company was founded in 1893 and is headquartered in Lake Zurich, Illinois.",
         "337871648.0",
         "3.75",
         "19.57728499960462",
         "21.280011017769226",
         "4.67466960473846"
        ],
        [
         "ACCS",
         "Communication Services",
         "Advertising Agencies",
         "ACCESS Newswire Inc. provides solutions for public relations and investor relations in the United States and internationally. The company offers press release and optimizer, media database and pitching, media monitoring, and media room; ACCESSWIRE, a news dissemination and media outreach solution; and Webcaster Platform, a cloud-based webcast, webinar, and virtual meeting platform that delivers live and on-demand streaming of events to audiences of various sizes, as well as allows customers to create, produce, and deliver events. It also offers professional conference and events software, a mobile app that offers one-on-one meetings, as well as manage schedules and lodging, perform event promotion and sponsorship, and print attendee badges; and investor relations content network, a series of data feeds, which include news feeds, stock feeds, fundamentals, regulatory filings, corporate governance, and other components. In addition, the company provides whistleblower hotline, a system that delivers secure notifications and basic incident workflow management processes that align with a company's corporate governance policies. It serves public and private companies. The company was formerly known as Issuer Direct Corporation and changed its name to ACCESS Newswire Inc. in January 2025. ACCESS Newswire Inc. was incorporated in 1988 and is headquartered in Raleigh, North Carolina.",
         "46249836.0",
         "12.020000457763672",
         "5.588952510315445",
         "2421.9597567508868",
         "200.49414846207867"
        ],
        [
         "ACDC",
         "Energy",
         "Oil & Gas Equipment & Services",
         "ProFrac Holding Corp. operates as a technology-focused energy services holding company in the United States. It operates through three segments: Stimulation Services, Proppant Production, and Manufacturing. The company offers hydraulic fracturing, proppant production, well stimulation, in-basin frac sand, and other completion services and complementary products and services to upstream oil and natural gas companies engaged in the exploration and production of unconventional oil and natural gas resources. It also manufactures and sells high horsepower pumps, valves, piping, swivels, large-bore manifold systems, and fluid ends, as well as other auxiliary equipment. The company was founded in 2016 and is headquartered in Willow Park, Texas.",
         "1270211456.0",
         "7.929999828338623",
         "-10.83380101756647",
         null,
         null
        ]
       ],
       "shape": {
        "columns": 8,
        "rows": 6315
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Sector</th>\n",
       "      <th>Industry</th>\n",
       "      <th>Long Business Summary</th>\n",
       "      <th>Market Cap</th>\n",
       "      <th>Price</th>\n",
       "      <th>Forward PER Fair Price (This Year)</th>\n",
       "      <th>Forward PEGR Fair Price (This Year)</th>\n",
       "      <th>Upside Potential</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Ticker</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>A</th>\n",
       "      <td>Healthcare</td>\n",
       "      <td>Diagnostics &amp; Research</td>\n",
       "      <td>Agilent Technologies, Inc. provides applicatio...</td>\n",
       "      <td>3.305379e+10</td>\n",
       "      <td>113.989998</td>\n",
       "      <td>99.454599</td>\n",
       "      <td>163.713185</td>\n",
       "      <td>0.436207</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>AA</th>\n",
       "      <td>Basic Materials</td>\n",
       "      <td>Aluminum</td>\n",
       "      <td>Alcoa Corporation, together with its subsidiar...</td>\n",
       "      <td>7.852497e+09</td>\n",
       "      <td>30.330000</td>\n",
       "      <td>53.930343</td>\n",
       "      <td>392.331302</td>\n",
       "      <td>11.935420</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>AACB</th>\n",
       "      <td>Financial Services</td>\n",
       "      <td>Shell Companies</td>\n",
       "      <td>Artius II Acquisition Inc. does not have signi...</td>\n",
       "      <td>2.972340e+08</td>\n",
       "      <td>10.110000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>AACBU</th>\n",
       "      <td>Financial Services</td>\n",
       "      <td>Shell Companies</td>\n",
       "      <td>Artius II Acquisition Inc. does not have signi...</td>\n",
       "      <td>2.668550e+08</td>\n",
       "      <td>10.600000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>AACG</th>\n",
       "      <td>Consumer Defensive</td>\n",
       "      <td>Education &amp; Training Services</td>\n",
       "      <td>ATA Creativity Global, together with its subsi...</td>\n",
       "      <td>2.593209e+07</td>\n",
       "      <td>0.820000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ZVRA</th>\n",
       "      <td>Healthcare</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Zevra Therapeutics, Inc., a commercial-stage c...</td>\n",
       "      <td>6.599828e+08</td>\n",
       "      <td>12.070000</td>\n",
       "      <td>19.458090</td>\n",
       "      <td>263.523166</td>\n",
       "      <td>20.832906</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ZWS</th>\n",
       "      <td>Industrials</td>\n",
       "      <td>Pollution &amp; Treatment Controls</td>\n",
       "      <td>Zurn Elkay Water Solutions Corporation engages...</td>\n",
       "      <td>6.317862e+09</td>\n",
       "      <td>37.549999</td>\n",
       "      <td>27.930538</td>\n",
       "      <td>389.556789</td>\n",
       "      <td>9.374349</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ZYBT</th>\n",
       "      <td>Healthcare</td>\n",
       "      <td>Drug Manufacturers - Specialty &amp; Generic</td>\n",
       "      <td>Zhengye Biotechnology Holding Limited engages ...</td>\n",
       "      <td>2.696571e+08</td>\n",
       "      <td>5.690000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ZYME</th>\n",
       "      <td>Healthcare</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Zymeworks Inc., a clinical-stage biotechnology...</td>\n",
       "      <td>1.066534e+09</td>\n",
       "      <td>14.250000</td>\n",
       "      <td>-28.074039</td>\n",
       "      <td>-89.115161</td>\n",
       "      <td>-7.253695</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ZYXI</th>\n",
       "      <td>Healthcare</td>\n",
       "      <td>Medical Distribution</td>\n",
       "      <td>Zynex, Inc., together with its subsidiaries, d...</td>\n",
       "      <td>6.985186e+07</td>\n",
       "      <td>2.310000</td>\n",
       "      <td>-13.192771</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>6315 rows × 8 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                    Sector                                  Industry  \\\n",
       "Ticker                                                                 \n",
       "A               Healthcare                    Diagnostics & Research   \n",
       "AA         Basic Materials                                  Aluminum   \n",
       "AACB    Financial Services                           Shell Companies   \n",
       "AACBU   Financial Services                           Shell Companies   \n",
       "AACG    Consumer Defensive             Education & Training Services   \n",
       "...                    ...                                       ...   \n",
       "ZVRA            Healthcare                             Biotechnology   \n",
       "ZWS            Industrials            Pollution & Treatment Controls   \n",
       "ZYBT            Healthcare  Drug Manufacturers - Specialty & Generic   \n",
       "ZYME            Healthcare                             Biotechnology   \n",
       "ZYXI            Healthcare                      Medical Distribution   \n",
       "\n",
       "                                    Long Business Summary    Market Cap  \\\n",
       "Ticker                                                                    \n",
       "A       Agilent Technologies, Inc. provides applicatio...  3.305379e+10   \n",
       "AA      Alcoa Corporation, together with its subsidiar...  7.852497e+09   \n",
       "AACB    Artius II Acquisition Inc. does not have signi...  2.972340e+08   \n",
       "AACBU   Artius II Acquisition Inc. does not have signi...  2.668550e+08   \n",
       "AACG    ATA Creativity Global, together with its subsi...  2.593209e+07   \n",
       "...                                                   ...           ...   \n",
       "ZVRA    Zevra Therapeutics, Inc., a commercial-stage c...  6.599828e+08   \n",
       "ZWS     Zurn Elkay Water Solutions Corporation engages...  6.317862e+09   \n",
       "ZYBT    Zhengye Biotechnology Holding Limited engages ...  2.696571e+08   \n",
       "ZYME    Zymeworks Inc., a clinical-stage biotechnology...  1.066534e+09   \n",
       "ZYXI    Zynex, Inc., together with its subsidiaries, d...  6.985186e+07   \n",
       "\n",
       "             Price  Forward PER Fair Price (This Year)  \\\n",
       "Ticker                                                   \n",
       "A       113.989998                           99.454599   \n",
       "AA       30.330000                           53.930343   \n",
       "AACB     10.110000                            0.000000   \n",
       "AACBU    10.600000                            0.000000   \n",
       "AACG      0.820000                            0.000000   \n",
       "...            ...                                 ...   \n",
       "ZVRA     12.070000                           19.458090   \n",
       "ZWS      37.549999                           27.930538   \n",
       "ZYBT      5.690000                            0.000000   \n",
       "ZYME     14.250000                          -28.074039   \n",
       "ZYXI      2.310000                          -13.192771   \n",
       "\n",
       "        Forward PEGR Fair Price (This Year)  Upside Potential  \n",
       "Ticker                                                         \n",
       "A                                163.713185          0.436207  \n",
       "AA                               392.331302         11.935420  \n",
       "AACB                                    NaN               NaN  \n",
       "AACBU                                   NaN               NaN  \n",
       "AACG                                    NaN               NaN  \n",
       "...                                     ...               ...  \n",
       "ZVRA                             263.523166         20.832906  \n",
       "ZWS                              389.556789          9.374349  \n",
       "ZYBT                                    NaN               NaN  \n",
       "ZYME                             -89.115161         -7.253695  \n",
       "ZYXI                                    NaN               NaN  \n",
       "\n",
       "[6315 rows x 8 columns]"
      ]
     },
     "execution_count": 29,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "get_upside_potential(db.value_summary)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 101,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "Ticker",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "Long Name",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "Sector",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "Industry",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "Long Business Summary",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "Quote Type",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "Last Fiscal Year End",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "Shares Outstanding",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "Market Cap",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "Enterprise Value",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "Trailing Pe",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "Forward Pe",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "Trailing Eps",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "Forward Eps",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "Trailing Peg Ratio",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "Beta",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "Price",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "Forward EPS (This Year)",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "Forward EPS (Next Year)",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "Forward EPS Growth (CAGR)",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "Forward PER (This Year)",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "Forward PER (Next Year)",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "Forward PEGR (This Year)",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "Forward PEGR (Next Year)",
         "rawType": "float64",
         "type": "float"
        }
       ],
       "ref": "f6ff198c-616d-4701-9dda-77935075ae3c",
       "rows": [
        [
         "A",
         "Agilent Technologies, Inc.",
         "Healthcare",
         "Diagnostics & Research",
         "Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. This segment also offers GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies. The Diagnostics and Genomics segment provides genomics, contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses; and cell analysis plate based assays, flow cytometers, real-time cell analyzers, cell imaging systems, microplate readers, and related consumables. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.",
         "EQUITY",
         "2024-10-31",
         "284064992.0",
         "33053794304.0",
         "35720478720.0",
         "28.076355",
         "20.17522",
         "4.06",
         "5.65",
         "1.6741",
         "1.232",
         "113.98999786376953",
         "5.57854",
         "6.0623",
         "0.07047893486980872",
         "20.433661471239702",
         "18.80309418269791",
         "2.899257985238499",
         "2.6679027169510547"
        ],
        [
         "AA",
         "Alcoa Corporation",
         "Basic Materials",
         "Aluminum",
         "Alcoa Corporation, together with its subsidiaries, engages in the bauxite mining, alumina refining, aluminum production, and energy generation business in Australia, Brazil, Canada, Iceland, Norway, Spain, the United States, and internationally. The company operates through two segments, Alumina and Aluminum. It operates bauxite and other aluminous ores mining; and processes bauxite into alumina for sale to aluminum smelter customers and customers who process it into industrial chemical products through supply contracts to third parties, as well as aluminum smelting and casting businesses. The company offers primary aluminum in the form of alloy ingot or value-add ingot to customers that produce products for transportation, building and construction, packaging, wire, other industrial markets, and traders. In addition, it provides energy that generates and sells electricity in the wholesale market to traders, large industrial consumers, distribution companies, and other generation companies. The company was formerly known as Alcoa Upstream Corporation and changed its name to Alcoa Corporation in October 2016. The company was founded in 1886 and is headquartered in Pittsburgh, Pennsylvania.",
         "EQUITY",
         "2024-12-31",
         "258902000.0",
         "7852497408.0",
         "9234207744.0",
         "18.271084",
         "9.507836",
         "1.66",
         "3.19",
         null,
         "2.257",
         "30.329999923706055",
         "3.40869",
         "2.87543",
         "0.45948277644856095",
         "8.89784636435289",
         "10.547987578799015",
         "0.19364918165434225",
         "0.22956219731078129"
        ],
        [
         "AACB",
         "Artius II Acquisition Inc.",
         "Financial Services",
         "Shell Companies",
         "Artius II Acquisition Inc. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intend to focus on technology enabled businesses that offer technology software and services, or financial services. The company was incorporated in 2024 and is based in New York, New York.",
         "EQUITY",
         "2024-12-31",
         "23650000.0",
         "297233984.0",
         "297171872.0",
         null,
         null,
         null,
         null,
         null,
         null,
         "10.109999656677246",
         "0.0",
         "0.0",
         null,
         null,
         null,
         null,
         null
        ],
        [
         "AACBU",
         "Artius II Acquisition Inc.",
         "Financial Services",
         "Shell Companies",
         "Artius II Acquisition Inc. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intend to focus on technology enabled businesses that offer technology software and services, or financial services. The company was incorporated in 2024 and is based in New York, New York.",
         "EQUITY",
         "2024-12-31",
         "25175000.0",
         "266855008.0",
         "308343872.0",
         null,
         null,
         null,
         null,
         null,
         null,
         "10.600000381469727",
         "0.0",
         "0.0",
         null,
         null,
         null,
         null,
         null
        ],
        [
         "AACG",
         "ATA Creativity Global",
         "Consumer Defensive",
         "Education & Training Services",
         "ATA Creativity Global, together with its subsidiaries, provides educational services in China and internationally. The company offers portfolio training services, research-based learning services, overseas study counselling services, in-school art classes through cooperation with high schools and training organizations, junior art education, and other educational services to students. It also provides online courses for students. The company provides its services through partnership with sales channels, internet and mobile advertisement, word of mouth referral, and marketing events and activities. The company was formerly known as ATA Inc. and changed its name to ATA Creativity Global in September 2019. ATA Creativity Global was founded in 1999 and is based in Hefei, China.",
         "EQUITY",
         "2024-12-31",
         "31624500.0",
         "25932090.0",
         "56383208.0",
         null,
         "-0.82828283",
         "-0.14",
         "-0.99",
         null,
         "0.884",
         "0.8199999928474426",
         "0.0",
         "0.0",
         null,
         null,
         null,
         null,
         null
        ],
        [
         "AACT",
         "Ares Acquisition Corporation II",
         "Financial Services",
         "Shell Companies",
         "Ares Acquisition Corporation II does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in New York, New York.",
         "EQUITY",
         "2024-12-31",
         "61859700.0",
         "702726144.0",
         "705213248.0",
         "30.702702",
         null,
         "0.37",
         null,
         null,
         "0.006",
         "11.359999656677246",
         "0.0",
         "0.0",
         null,
         null,
         null,
         null,
         null
        ],
        [
         "AAL",
         "American Airlines Group Inc.",
         "Industrials",
         "Airlines",
         "American Airlines Group Inc., through its subsidiaries, operates as a network air carrier in the United States, Latin America, Atlantic, and Pacific. The company provides scheduled air transportation services for passengers and cargo through its hubs in Charlotte, Chicago, Dallas/Fort Worth, Los Angeles, Miami, New York, Philadelphia, Phoenix, and Washington, D.C., as well as through partner gateways in London, Doha, Madrid, Seattle/Tacoma, Sydney, and Tokyo. It also operates a mainline fleet of 977 aircraft. The company was formerly known as AMR Corporation and changed its name to American Airlines Group Inc. in December 2013. American Airlines Group Inc. was founded in 1926 and is headquartered in Fort Worth, Texas.",
         "EQUITY",
         "2024-12-31",
         "659512000.0",
         "8250495488.0",
         "36133728256.0",
         "12.51",
         "6.1930695",
         "1.0",
         "2.02",
         "0.5878",
         "1.38",
         "12.510000228881836",
         "0.89523",
         "2.0286",
         "0.017291566867631003",
         "13.9740627870847",
         "6.166814664735204",
         "8.081432350265196",
         "3.566371232834423"
        ],
        [
         "AAM",
         "AA Mission Acquisition Corp.",
         "Financial Services",
         "Shell Companies",
         "AA Mission Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. AA Mission Acquisition Corp. was incorporated in 2024 and is based in The Woodlands, Texas.",
         "EQUITY",
         "2024-12-31",
         "35349000.0",
         "459528288.0",
         "458151168.0",
         null,
         null,
         null,
         null,
         null,
         null,
         "10.449999809265137",
         "0.0",
         "0.0",
         null,
         null,
         null,
         null,
         null
        ],
        [
         "AAME",
         "Atlantic American Corporation",
         "Financial Services",
         "Insurance - Life",
         "Atlantic American Corporation, through its subsidiaries, provides life and health, and property and casualty insurance products in the United States. It operates through American Southern and Bankers Fidelity segments. The company offers property and casualty insurance products, including commercial automobile insurance coverage for state governments, local municipalities, and other motor pools and fleets; general liability insurance; and inland marine insurance products. It also provides surety bond coverage for subdivision construction; school bus contracts; and performance and payment bonds. In addition, the company offers individual and group whole life insurance products; Medicare supplement insurance products; other accident and health insurance products comprising various individual and group policies for the payment of standard benefits for the treatment of cancer and other critical illnesses; Vantage Flex Plus, a hospital indemnity plan; and Vantage Recovery short-term care product and a group whole life product. It markets its products through independent agents and brokers. The company was founded in 1937 and is based in Atlanta, Georgia. Atlantic American Corporation operates as a subsidiary of Atlantic American / Delta Group.",
         "EQUITY",
         "2024-12-31",
         "20397200.0",
         "44363908.0",
         "50532096.0",
         null,
         null,
         "-0.1",
         null,
         null,
         "0.706",
         "2.1700000762939453",
         "0.0",
         "0.0",
         null,
         null,
         null,
         null,
         null
        ],
        [
         "AAMI",
         "Acadian Asset Management Inc.",
         "Financial Services",
         "Asset Management",
         "BrightSphere Investment Group Inc. is a publically owned asset management holding company. The firm provides its services to individuals and institutions. It manages separate client focused portfolios through its subsidiaries. The firm also launches equity mutual funds for its clients. It invests in public equity, fixed income, and alternative investment markets through its subsidiaries. The firm was founded in 1980 is based Boston, Massachusetts. It was formally known as BrightSphere Investment Group plc. BrightSphere Investment Group Inc. was formed in 1980 and is based in Boston, Massachusetts.",
         "EQUITY",
         "2024-12-31",
         "35795300.0",
         "1433959808.0",
         "1632525440.0",
         "16.761507",
         "12.557994",
         "2.39",
         null,
         null,
         "1.341",
         "40.060001373291016",
         "2.78333",
         "3.19",
         "0.07510085573400982",
         "14.392832101580128",
         "12.557994160906274",
         "1.9164671242304177",
         "1.672150608427664"
        ],
        [
         "AAOI",
         "Applied Optoelectronics, Inc.",
         "Technology",
         "Communication Equipment",
         "Applied Optoelectronics, Inc. designs, manufactures, and sells fiber-optic networking products in the United States, Taiwan, and China. It offers optical modules, optical filters, lasers, laser components, subassemblies, transmitters and transceivers, turn-key equipment, headend, node, and distribution equipment, as well as amplifiers. The company sells its products to internet data center operators, cable television, telecom equipment manufacturers, fiber-to-the-home, and internet service providers through its direct and indirect sales channels. Applied Optoelectronics, Inc. was incorporated in 1997 and is headquartered in Sugar Land, Texas.",
         "EQUITY",
         "2024-12-31",
         "56139100.0",
         "1607262336.0",
         "1566091392.0",
         null,
         "39.219177",
         "-4.08",
         "0.73",
         null,
         "2.628",
         "28.6299991607666",
         "0.04",
         "1.27333",
         "7.079440939685728",
         "715.749979019165",
         "22.48435139419208",
         "1.0110261320308984",
         "0.031760066346694045"
        ],
        [
         "AAON",
         "AAON, Inc.",
         "Industrials",
         "Building Products & Equipment",
         "AAON, Inc., together with its subsidiaries, engages in engineering, manufacturing, marketing, and selling air conditioning and heating equipment in the United States and Canada. The company operates through three segments: AAON Oklahoma, AAON Coil Products, and BASX. It offers rooftop units, data center cooling solutions, cleanroom systems, chillers, packaged outdoor mechanical rooms, air handling units, makeup air units, energy recovery units, condensing units, geothermal/water-source heat pumps, coils, and controls. The company markets and sells its products to retail, manufacturing, educational, lodging, supermarket, data centers, medical and pharmaceutical, and other commercial industries. It sells its products through a network of independent manufacturer representative organizations and internal sales force, as well as online. AAON, Inc. was incorporated in 1987 and is headquartered in Tulsa, Oklahoma.",
         "EQUITY",
         "2024-12-31",
         "81366096.0",
         "6402698240.0",
         "6037893632.0",
         "41.198956",
         "26.856655",
         "1.91",
         "2.93",
         null,
         "1.031",
         "78.69000244140625",
         "2.04",
         "2.668",
         "0.1492376690658901",
         "38.57353060853247",
         "29.494003913570555",
         "2.5847047096066498",
         "1.9763109473753993"
        ],
        [
         "AAP",
         "Advance Auto Parts, Inc.",
         "Consumer Cyclical",
         "Auto Parts",
         "Advance Auto Parts, Inc. engages in the provision of automotive aftermarket parts in the United States and internationally. The company offers batteries and battery accessories; belts and hoses; brakes and brake pads; chassis parts; climate control parts; clutches and drive shafts; engines and engine parts; exhaust systems and parts; hub assemblies; ignition components and wire; radiators and cooling parts; starters and alternators; and steering and alignment parts. It also provides air conditioning chemicals and accessories; air fresheners; antifreeze and washer fluid; electrical wire and fuses; electronics; floor mats, seat covers and interior accessories; hand and specialty tools; lighting; performance parts; sealants, adhesives and compounds; tire repair accessories; vent shades, mirrors and exterior accessories; washes, waxes and cleaning supplies; and wiper blades. In addition, the company offers air filters; fuel and oil additives; fuel filters; grease and lubricants; motor oil; oil filters; part cleaners and treatments; and transmission fluid. Further, it provides battery and wiper installation; engine light scanning and checking; electrical system testing, including batteries, starters, and alternators; oil and battery recycling; and loaner tool program services. The company serves professional installers and do-it-yourself customers. It operates stores under the Advance Auto Parts and Carquest names. The company has stores in the United States, Puerto Rico, the U.S. Virgin Islands, and Canada; and independently owned Carquest branded stores in Mexico and the Caribbean Islands. Advance Auto Parts, Inc. was founded in 1929 and is based in Raleigh, North Carolina.",
         "EQUITY",
         "2024-12-28",
         "59925600.0",
         "3663251968.0",
         "5190942720.0",
         null,
         "22.724907",
         "-9.73",
         "2.69",
         "3.0642",
         "1.09",
         "61.130001068115234",
         "1.86091",
         "3.21358",
         "2.8124985175965644",
         "32.849520432538505",
         "19.022399027911312",
         "0.1167983564329493",
         "0.06763523219264486"
        ],
        [
         "AAPG",
         "",
         "Healthcare",
         "Biotechnology",
         "Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company's primary product candidate is HQP1351, a BCR-ABL inhibitor targeting BCR-ABL1 mutants, including those with the T315I mutation. It also develops APG-2575, an oral administered Bcl-2 selective inhibitor for hematologic malignancies and solid tumors; APG-115, an oral small molecule inhibitor of the MDM2-p53 protein-protein interactions to treat solid tumors and hematological malignancies; and APG-1252, a small molecule drug to restore apoptosis through dual inhibition of the Bcl-2 and Bcl-xL proteins for the treatment of small-cell lung cancer, non-small cell lung cancer, neuroendocrine tumor, and non-Hodgkin's lymphoma. In addition, the company is developing APG-1387, a small-molecule inhibitor of apoptosis proteins for advanced solid tumors and chronic HBV infection; APG-2449, an oral inhibitor of FAK, ROS1, and ALK kinases; APG-5918, an orally available and selective embryonic ectoderm development inhibitor. In addition, it is also involved in medical research and development; clinical development; clinical trials operations; venture capital investment; rental of buildings; and science and technology promotion services. The company has collaboration relationships with biotechnology and pharmaceutical companies; and research institutions. Ascentage Pharma Group International was founded in 2009 and is headquartered in Suzhou, China.",
         "EQUITY",
         "2024-12-31",
         "92612200.0",
         "3740606720.0",
         "12711531520.0",
         null,
         "42.072918",
         "-0.75",
         null,
         null,
         "0.782",
         "40.38999938964844",
         "-2.57",
         "0.96",
         null,
         null,
         "42.07291603088379",
         null,
         null
        ],
        [
         "AAPL",
         "Apple Inc.",
         "Technology",
         "Consumer Electronics",
         "Apple Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide. The company offers iPhone, a line of smartphones; Mac, a line of personal computers; iPad, a line of multi-purpose tablets; and wearables, home, and accessories comprising AirPods, Apple TV, Apple Watch, Beats products, and HomePod. It also provides AppleCare support and cloud services; and operates various platforms, including the App Store that allow customers to discover and download applications and digital content, such as books, music, video, games, and podcasts, as well as advertising services include third-party licensing arrangements and its own advertising platforms. In addition, the company offers various subscription-based services, such as Apple Arcade, a game subscription service; Apple Fitness+, a personalized fitness service; Apple Music, which offers users a curated listening experience with on-demand radio stations; Apple News+, a subscription news and magazine service; Apple TV+, which offers exclusive original content; Apple Card, a co-branded credit card; and Apple Pay, a cashless payment service, as well as licenses its intellectual property. The company serves consumers, and small and mid-sized businesses; and the education, enterprise, and government markets. It distributes third-party applications for its products through the App Store. The company also sells its products through its retail and online stores, and direct sales force; and third-party cellular network carriers, wholesalers, retailers, and resellers. Apple Inc. was founded in 1976 and is headquartered in Cupertino, California.",
         "EQUITY",
         "2024-09-28",
         "14935799808.0",
         "3154142035968.0",
         "3114071490560.0",
         "32.89408",
         "25.412754",
         "6.42",
         "8.31",
         "1.969",
         "1.211",
         "211.17999267578125",
         "7.17392",
         "7.81045",
         "0.13338304165582082",
         "29.437182555113697",
         "27.038133868827178",
         "2.206965907335722",
         "2.027104310501172"
        ],
        [
         "AARD",
         "Aardvark Therapeutics, Inc.",
         "Healthcare",
         "Biotechnology",
         "Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Its lead product candidate is ARD-101, an oral gut-restricted small-molecule agonist of certain targeting bitter taste receptors expressed in the gut lumen, which is in the Phase 3 clinical trial for hyperphagia associated with Prader-Willi Syndrome, as well as in the Phase 2 clinical trial for hyperphagia associated with acquired hypothalamic obesity resultant from the treatment of craniopharyngioma, including surgery or radiation. The company is also developing ARD-201, which is in the Phase 1 clinical trial for the treatment of obesity. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.",
         "EQUITY",
         "2024-12-31",
         "21688200.0",
         "252016880.0",
         "142794832.0",
         null,
         "-4.4393506",
         "-1.28",
         null,
         null,
         null,
         "11.619999885559082",
         "-2.67",
         "-2.6175",
         "0.22914096831893138",
         null,
         null,
         null,
         null
        ],
        [
         "AAT",
         "American Assets Trust, Inc.",
         "Real Estate",
         "REIT - Diversified",
         "American Assets Trust, Inc. is a full service, vertically integrated and self-administered real estate investment trust (\"REIT\"), headquartered in San Diego, California. The company has over 55 years of experience in acquiring, improving, developing and managing premier office, retail, and residential properties throughout the United States in some of the nation's most dynamic, high-barrier-to-entry markets primarily in Southern California, Northern California, Washington, Oregon, Texas and Hawaii. The company's office portfolio comprises approximately 4.1 million rentable square feet, and its retail portfolio comprises approximately 2.4 million rentable square feet. In addition, the company owns one mixed-use property (including approximately 94,000 rentable square feet of retail space and a 369-room all-suite hotel) and 2,302 multifamily units. In 2011, the company was formed to succeed to the real estate business of American Assets, Inc., a privately held corporation founded in 1967 and, as such, has significant experience, long-standing relationships and extensive knowledge of its core markets, submarkets and asset classes.",
         "EQUITY",
         "2024-12-31",
         "61134700.0",
         "1557150336.0",
         "2719488000.0",
         "15.257575",
         "27.97222",
         "1.32",
         "0.72",
         null,
         "1.185",
         "20.139999389648438",
         "0.0",
         "0.0",
         null,
         null,
         null,
         null,
         null
        ],
        [
         "AAUC",
         "Allied Gold Corporation",
         "Basic Materials",
         "Gold",
         "Allied Gold Corporation, together with its subsidiaries, explores and produces mineral deposits in Africa. The company primarily explores for gold and silver ores. Its flagship project is the Sadiola gold project, an open pit mine located in the Republic of Mali. The company holds interest in the Bonikro and Hiré mines located in Côte d'Ivoire; the Agbaou mine located in Côte d'Ivoire; and the Kurmuk gold project located in Ethiopia. The company was formerly known as Allied Gold Corp Limited & Allied Merger Corporation and changed its name to Allied Gold Corporation in September 2023. Allied Gold Corporation is based in Toronto, Canada.",
         "EQUITY",
         "2024-12-31",
         "115379000.0",
         "1559924096.0",
         "1559932160.0",
         null,
         null,
         "-1.11",
         null,
         null,
         null,
         "13.520000457763672",
         "0.0",
         "0.0",
         null,
         null,
         null,
         null,
         null
        ],
        [
         "AB",
         "AllianceBernstein Holding L.P.",
         "Financial Services",
         "Asset Management",
         "AllianceBernstein Holding L.P. is a publicly owned investment manager. The firm is a related adviser The firm manages separate client focused portfolios for its clients. The firm primarily invests in common and preferred stocks, warrants and convertible securities, government and corporate fxed-income securities, commodities, currencies, real estate-related assets and infation-protected securities. The firm employs quantitative analysis along with long-term purchases, short-term purchases, trading, short sales, margin transactions, option strategies including writing covered options, uncovered options and spread strategies to make its investments. The firm obtains external research to complement its in-house research. The firm was formerly known as Alliance Capital Management Holding LP. AllianceBernstein Holding L.P. was founded in 1967 and is based in Nashville,Tennessee.",
         "EQUITY",
         "2024-12-31",
         "110700000.0",
         "4561947136.0",
         null,
         "10.873351",
         "11.415512",
         "3.79",
         "3.61",
         null,
         "0.815",
         "41.209999084472656",
         "3.12617",
         "3.50243",
         "0.038129452428742105",
         "13.182264267289577",
         "11.766116406173044",
         "3.4572393327507487",
         "3.085834088009013"
        ],
        [
         "ABAT",
         "American Battery Technology Company",
         "Basic Materials",
         "Other Industrial Metals & Mining",
         "American Battery Technology Company operates as a battery materials company in the United States. The company explores for resources of battery metals, such as lithium, nickel, cobalt, and manganese; and develops and commercializes technologies for the extraction and refining of battery metals. It also commercializes an integrated process for the recycling of lithium-ion batteries. The company was formerly known as American Battery Metals Corporation and changed its name to American Battery Technology Company in August 2021. American Battery Technology Company was incorporated in 2011 and is headquartered in Reno, Nevada.",
         "EQUITY",
         "2024-06-30",
         "92523904.0",
         "222057376.0",
         "153083664.0",
         null,
         "-17.142859",
         "-0.91",
         "-0.14",
         null,
         "1.206",
         "2.4000000953674316",
         "0.0",
         "0.0",
         null,
         null,
         null,
         null,
         null
        ],
        [
         "ABBV",
         "AbbVie Inc.",
         "Healthcare",
         "Drug Manufacturers - General",
         "AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, generalized pustular psoriasis, and pyoderma gangrenosum; Skyrizi to treat autoimmune diseases, erythrodermic psoriasis, generalized pustular psoriasis, and palmoplantar pustulosis; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta/Venclyxto to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic to treat neurologic diseases; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duopa and Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; and Qulipta for episodic and chronic migraine, as well as other neuroscience products. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.",
         "EQUITY",
         "2024-12-31",
         "1766400000.0",
         "334308868096.0",
         "392769732608.0",
         "80.53617",
         "15.602637",
         "2.35",
         "12.13",
         "0.4046",
         "0.491",
         "189.25999450683594",
         "12.23703",
         "13.95654",
         "0.17434773899897293",
         "15.466170672690671",
         "13.560667221735182",
         "0.8870875390464215",
         "0.7777942690621911"
        ],
        [
         "ABCB",
         "Ameris Bancorp",
         "Financial Services",
         "Banks - Regional",
         "Ameris Bancorp operates as the bank holding company for Ameris Bank that provides range of banking services to retail and commercial customers. It operates through four segments: Banking Division, Retail Mortgage Division, Warehouse Lending Division, and Premium Finance Division. The company offers commercial and retail checking, regular interest-bearing savings, money market, individual retirement, and certificates of deposit accounts. It also provides commercial real estate, residential real estate mortgage, agricultural, and commercial and industrial loans; consumer loans, including motor vehicle, home improvement, and home equity loans, as well as loans secured by savings accounts and personal credit lines. In addition, the company originates, administers, and services commercial insurance premium loans, equipment finance loans, and small business administration loans. Further, it operates full-service domestic banking offices, and mortgage and loan production offices. The company was founded in 1971 and is headquartered in Atlanta, Georgia.",
         "EQUITY",
         "2024-12-31",
         "68910896.0",
         "4640459264.0",
         "3555894784.0",
         "12.516727",
         "13.387672",
         "5.38",
         "5.03",
         null,
         "0.94",
         "67.33999633789062",
         "5.352",
         "5.77167",
         "0.07223236287662949",
         "12.582211572849518",
         "11.667333083473348",
         "1.7419077919878552",
         "1.6152500927320863"
        ],
        [
         "ABCL",
         "AbCellera Biologics Inc.",
         "Healthcare",
         "Biotechnology",
         "AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.",
         "EQUITY",
         "2024-12-31",
         "298484992.0",
         "1337212800.0",
         "486383392.0",
         null,
         "-6.7878785",
         "-0.64",
         "-0.66",
         null,
         "0.36",
         "4.480000019073486",
         "-0.645",
         "-0.632",
         "-0.0812990366827735",
         null,
         null,
         null,
         null
        ],
        [
         "ABEO",
         "Abeona Therapeutics Inc.",
         "Healthcare",
         "Biotechnology",
         "Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is pz-cel, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio.",
         "EQUITY",
         "2024-12-31",
         "51156700.0",
         "339168864.0",
         "230392256.0",
         null,
         "-4.4527025",
         "-0.63",
         "-1.48",
         null,
         "1.547",
         "6.590000152587891",
         "-0.46",
         "-0.2075",
         "0.6227876379995012",
         null,
         null,
         null,
         null
        ],
        [
         "ABEV",
         "Ambev S.A.",
         "Consumer Defensive",
         "Beverages - Brewers",
         "Ambev S.A., through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, malt and food, other alcoholic beverages, and non-alcoholic and non-carbonated products in Brazil, Central America and Caribbean, Latin America South, and Canada. It offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Budweiser, Bud Light, Beck, Leffe, Hoegaarden, Balboa ICE, Balboa, Atlas Golden Light, Atlas, Bucanero, Cristal, Mayabe, Presidente, Presidente Light, Brahma Light, Bohemia, The One, Corona, Modelo Especial, Stella Artois, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Michelob Ultra, Busch, Pilsen, Ouro Fino, Bud 66, Banks, Deputy, Patricia, Labatt Blue, Alexander Keith's, and Kokanee brands. The company also provides carbonated soft drinks, bottled water, isotonic beverages, energy drinks, coconut water, powdered and natural juices, and ready-to-drink teas under the Guaraná Antarctica, Gatorade, H2OH!, Pepsi Black, Lipton Iced Tea, Fusion, Pepsi-Cola, Canada Dry, Squirt, Red Rock, Red Bull, Seven Up, Nutrl, Bud Light Seltzer, Palm Bay, and Mike's brands. It offers its products through a network of third-party distributors and a direct distribution system. The company was founded in 1885 and is headquartered in São Paulo, Brazil. Ambev S.A. operates as a subsidiary of Interbrew International B.V.",
         "EQUITY",
         "2024-12-31",
         "15592200192.0",
         "38382784512.0",
         "21565196288.0",
         "14.6875",
         "12.368421",
         "0.16",
         "0.19",
         "1.3367",
         "0.352",
         "2.3499999046325684",
         "0.18327",
         "0.1975",
         "0.11900455763146911",
         "12.822610927225233",
         "11.898733694342118",
         "1.0774890628083365",
         "0.9998552938778927"
        ],
        [
         "ABG",
         "Asbury Automotive Group, Inc.",
         "Consumer Cyclical",
         "Auto & Truck Dealerships",
         "Asbury Automotive Group, Inc., together with its subsidiaries, operates as an automotive retailer in the United States. It operates through Dealerships and Total Care Auto, Powered by Landcar (TCA) segments. The company offers a range of automotive products and services, including new and used vehicles; and vehicle repair and maintenance services, replacement parts, collision repair, and recondition of used vehicle services. It also provides finance and insurance products, including arranging vehicle financing through third parties; and aftermarket products, such as extended vehicle service contracts, guaranteed asset protection debt cancellation, prepaid maintenance contracts, key replacement contracts, paintless debt repair contracts, appearance protection contracts, tire and wheel, and lease wear and tear contracts. The company sells its products and services to individual retail customers, other dealers, and licensed wholesalers through its network of dealerships and at auctions. Asbury Automotive Group, Inc. was founded in 1996 and is headquartered in Duluth, Georgia.",
         "EQUITY",
         "2024-12-31",
         "19659200.0",
         "4520829952.0",
         "9357895680.0",
         "10.950477",
         "8.304803",
         "21.0",
         "27.69",
         "0.7147",
         "0.964",
         "229.9600067138672",
         "26.88884",
         "26.48631",
         "-0.0139505587991543",
         "8.552247204188324",
         "8.682221370733304",
         null,
         null
        ],
        [
         "ABL",
         "Abacus Global Management, Inc.",
         "Financial Services",
         "Insurance - Life",
         "Abacus Global Management, Inc. operates as an alternative asset manager and market maker in the United States. It operates in five segments: Active Management, Originations, Asset Management, Portfolio Servicing, and Technology Services. The Active Management segment is involved in the buying, selling, and trading of policies; and the maintenance of policies until receipt of death benefits. Its Originations segment originates life insurance policy settlements between investors or buyers, and the sellers, who are often the original policy owners. The Asset Management segment provides asset management services to investors investing in alternative investment and equity portfolio funds based on fund investment agreements. Its Portfolio Servicing segment offers policy services to customers on a contract basis. The Technology Services segment provides real-time mortality verification, missing participant verification, and other services specific to the life insurance market services to customers on a contract basis. It sells its products through financial advisors or agents, direct-to-consumer, and traditional life settlements intermediaries. The company was formerly known as Abacus Life, Inc. and changed its name to Abacus Global Management, Inc. in February 2025. Abacus Global Management, Inc. was founded in 2004 and is headquartered in Orlando, Florida.",
         "EQUITY",
         "2024-12-31",
         "97867800.0",
         "495211072.0",
         "814616576.0",
         null,
         "6.2469134",
         "-0.27",
         "0.81",
         null,
         "0.105",
         "5.059999942779541",
         "0.758",
         "0.95",
         "0.19975625129982144",
         "6.67546166593607",
         "5.326315729241623",
         "0.3341803634428755",
         "0.26664075314705227"
        ],
        [
         "ABLV",
         "Able View Global Inc.",
         "Communication Services",
         "Advertising Agencies",
         "Able View Global Inc. operates as a brand management partners of beauty and personal care brands in China. It offers brand management services, such as strategy, branding, digital and social marketing, omni-channel sales, customer services, overseas logistics, and warehouse and fulfilment. The company was founded in 2022 and is headquartered in Shanghai, China.",
         "EQUITY",
         "2024-12-31",
         "24518500.0",
         "52353292.0",
         "50141628.0",
         null,
         null,
         "-0.17",
         null,
         null,
         "1.597",
         "1.059999942779541",
         "0.0",
         "0.0",
         null,
         null,
         null,
         null,
         null
        ],
        [
         "ABLVW",
         "Able View Global Inc.",
         "Communication Services",
         "Advertising Agencies",
         "Able View Global Inc. operates as a brand management partners of beauty and personal care brands in China. It offers brand management services, such as strategy, branding, digital and social marketing, omni-channel sales, customer services, overseas logistics, and warehouse and fulfilment. The company was founded in 2022 and is headquartered in Shanghai, China.",
         "EQUITY",
         "2024-12-31",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "1.597",
         null,
         "0.0",
         "0.0",
         null,
         null,
         null,
         null,
         null
        ],
        [
         "ABM",
         "ABM Industries Incorporated",
         "Industrials",
         "Specialty Business Services",
         "ABM Industries Incorporated, through its subsidiaries, engages in the provision of integrated facility, infrastructure, and mobility solutions in the United States and internationally. It operates through Business & Industry, Manufacturing & Distribution, Education, Aviation, and Technical Solutions segments. The company offers janitorial, facilities engineering, and parking services for commercial real estate properties, including corporate offices for high tech clients, sports and entertainment venues, and traditional hospitals and non-acute healthcare facilities; and vehicle maintenance and other services to rental car providers. It also offers integrated facility services, engineering, and other specialized services in various types of manufacturing, distribution, and data center facilities. In addition, the company delivers custodial and landscaping and grounds for public school districts, private schools, colleges, and universities. Further, it supports airlines and airports with services comprising passenger assistance, catering logistics, air cabin maintenance, and transportation services. Additionally, the company provides facility infrastructure, mechanical and electrical services; and electric vehicle power and microgrid systems design, installation, and maintenance services. ABM Industries Incorporated was founded in 1909 and is headquartered in New York, New York.",
         "EQUITY",
         "2024-10-31",
         "62258000.0",
         "2970951936.0",
         "4549301248.0",
         "38.176003",
         "13.038251",
         "1.25",
         "3.66",
         null,
         "0.825",
         "47.720001220703125",
         "3.74594",
         "4.13697",
         "0.07649752145752742",
         "12.739125885813207",
         "11.535012635021072",
         "1.6652991682725515",
         "1.5078936435117687"
        ],
        [
         "ABNB",
         "Airbnb, Inc.",
         "Consumer Cyclical",
         "Travel Services",
         "Airbnb, Inc., together with its subsidiaries, operates a platform that enables hosts to offer stays and experiences to guests worldwide. Its marketplace connects hosts and guests online or through mobile devices to book spaces and experiences. It also offers gift cards. The company was formerly known as AirBed & Breakfast, Inc. and changed its name to Airbnb, Inc. in November 2010. Airbnb, Inc. was founded in 2007 and is headquartered in San Francisco, California.",
         "EQUITY",
         "2024-12-31",
         "431601984.0",
         "85977800704.0",
         "72469938176.0",
         "35.365482",
         "30.964443",
         "3.94",
         "4.5",
         "1.988",
         "1.144",
         "139.33999633789062",
         "4.21397",
         "4.82685",
         "0.08368751030912969",
         "33.066205107746526",
         "28.86768727801581",
         "3.951151729284896",
         "3.449461833836699"
        ],
        [
         "ABOS",
         "Acumen Pharmaceuticals, Inc.",
         "Healthcare",
         "Biotechnology",
         "Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate Sabirnetug (ACU193), a recombinant humanized immunoglobulin gamma 2, which has completed the INTERCEPT-AD phase 1 clinical trial and in ALTITUDE-AD phase 2 clinical trial to target soluble amyloid-beta oligomers. It has a collaboration and license agreement with Halozyme, Inc. for the development of a subcutaneous formulation of Sabirnetug. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Newton, Massachusetts.",
         "EQUITY",
         "2024-12-31",
         "60573400.0",
         "90860096.0",
         "-49102828.0",
         null,
         "-0.98039216",
         "-1.94",
         "-1.53",
         null,
         "0.05",
         "1.5",
         "-1.97342",
         "-1.68315",
         "-0.014887519112664949",
         null,
         null,
         null,
         null
        ],
        [
         "ABP",
         "Abpro Corporation",
         "Healthcare",
         "Biotechnology",
         "Abpro Holdings, Inc., a biotechnology company, focuses on novel antibody constructs for immuno-oncology and ophthalmology. Its platforms include DiversImmune, a discovery platform that generates a diverse collection of proprietary antibodies against clinically validated and novel targets; and MultiMab, an engineering platform that provides the flexibility to combine antibody building blocks in different combinations and orientations to create fit for purpose novel full-length multi-specific antibody constructs. The company's lead product candidates include ABP-102, a next generation immuno-oncology TetraBi antibody targeting HER2 and CD3 is developed for the treatment of HER2+ solid tumors, including breast and gastric cancers; and ABP-201, a TetraBi antibody format that simultaneously inhibit VEGF and ANG-2 for the treatment of vascular diseases of the eye, including diabetic macular edema and wet age-related macular degeneration. It also develops ABP-110, a TetraBi antibody targeting GPC3 and CD3 for the treatment of hepatocellular carcinoma; and ABP-150, a TetraBi antibody targeting claudin 18.2 and CD3 for the treatment of gastric cancers. The company has strategic partnership with Celltrion Inc. and Abpro Bio International, Inc. Abpro Holdings, Inc. was incorporated in 2004 and is headquartered in Woburn, Massachusetts.",
         "EQUITY",
         "2024-12-31",
         "60787300.0",
         "12394530.0",
         "15471531.0",
         null,
         null,
         "-0.43",
         null,
         null,
         "-0.038",
         "0.20399999618530273",
         "0.0",
         "0.0",
         null,
         null,
         null,
         null,
         null
        ],
        [
         "ABPWW",
         "Abpro Holdings Inc",
         "Healthcare",
         "Biotechnology",
         "Abpro Holdings, Inc., a biotechnology company, focuses on novel antibody constructs for immuno-oncology and ophthalmology. Its platforms include DiversImmune, a discovery platform that generates a diverse collection of proprietary antibodies against clinically validated and novel targets; and MultiMab, an engineering platform that provides the flexibility to combine antibody building blocks in different combinations and orientations to create fit for purpose novel full-length multi-specific antibody constructs. The company's lead product candidates include ABP-102, a next generation immuno-oncology TetraBi antibody targeting HER2 and CD3 is developed for the treatment of HER2+ solid tumors, including breast and gastric cancers; and ABP-201, a TetraBi antibody format that simultaneously inhibit VEGF and ANG-2 for the treatment of vascular diseases of the eye, including diabetic macular edema and wet age-related macular degeneration. It also develops ABP-110, a TetraBi antibody targeting GPC3 and CD3 for the treatment of hepatocellular carcinoma; and ABP-150, a TetraBi antibody targeting claudin 18.2 and CD3 for the treatment of gastric cancers. The company has strategic partnership with Celltrion Inc. and Abpro Bio International, Inc. Abpro Holdings, Inc. was incorporated in 2004 and is headquartered in Woburn, Massachusetts.",
         "EQUITY",
         "2024-12-31",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "-0.038",
         null,
         "0.0",
         "0.0",
         null,
         null,
         null,
         null,
         null
        ],
        [
         "ABR",
         "Arbor Realty Trust, Inc.",
         "Real Estate",
         "REIT - Mortgage",
         "Arbor Realty Trust, Inc. invests in a diversified portfolio of structured finance assets in the multifamily, single-family rental, and commercial real estate markets in the United States. The company operates through Structured Business and Agency Business segments. It primarily invests in bridge and mezzanine loans, including junior participating interests in first mortgages, and preferred and direct equity, as well as real estate-related joint ventures, real estate-related notes, and various mortgage-related securities. In addition, the company offers bridge financing products to borrowers who seek short-term capital to be used in an acquisition of property; financing by making preferred equity investments in entities that directly or indirectly own real property; mezzanine financing in the form of loans that are subordinate to a conventional first mortgage loan and senior to the borrower's equity in a transaction; junior participation financing in the form of a junior participating interest in the senior debt; and financing products to borrowers who are looking to acquire conventional, workforce, and affordable single-family housing. Further, it underwrites, originates, sells, and services multifamily mortgage loans through conduit/commercial mortgage-backed securities programs. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was incorporated in 2003 and is headquartered in Uniondale, New York.",
         "EQUITY",
         "2024-12-31",
         "192160000.0",
         "2336769280.0",
         "12481014784.0",
         "10.883495",
         "7.3267975",
         "1.03",
         "1.53",
         null,
         "1.29",
         "11.210000038146973",
         "1.0625",
         "1.2",
         "-0.16957139825991063",
         "10.550588271197151",
         "9.34166669845581",
         null,
         null
        ],
        [
         "ABSI",
         "Absci Corporation",
         "Healthcare",
         "Biotechnology",
         "Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to design differentiated antibody therapeutics. Its preclinical development programs include ABS-101 for the treatment of inflammatory bowel disease; ABS-201 for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, and Owkin for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington.",
         "EQUITY",
         "2024-12-31",
         "127559000.0",
         "397984064.0",
         "202761536.0",
         null,
         "-4.3943663",
         "-0.93",
         "-0.71",
         null,
         "2.069",
         "3.119999885559082",
         "-0.79429",
         "-0.65857",
         "0.1629228263302771",
         null,
         null,
         null,
         null
        ],
        [
         "ABT",
         "Abbott Laboratories",
         "Healthcare",
         "Medical Devices",
         "Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company provides pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.",
         "EQUITY",
         "2024-12-31",
         "1739840000.0",
         "215166009344.0",
         "243334152192.0",
         "15.536432",
         "23.967054",
         "7.96",
         "5.16",
         null,
         "0.737",
         "123.66999816894531",
         "5.1552",
         "5.67962",
         "0.10279945139630886",
         "23.989369601362764",
         "21.774343735838897",
         "2.333608718287784",
         "2.118138126233301"
        ],
        [
         "ABTS",
         "Abits Group Inc.",
         "Financial Services",
         "Capital Markets",
         "Abits Group Inc., through its subsidiary, operates in the bitcoin mining business in the United States. It also provides in-house support services. The company was formerly known as Moxian (BVI) Inc and changed its name to Abits Group Inc. in November 2023. Abits Group Inc. was incorporated in 2021 and is based in Causeway Bay, Hong Kong.",
         "EQUITY",
         "2024-12-31",
         "2370140.0",
         "11163359.0",
         "7916113.0",
         null,
         null,
         "-0.38",
         null,
         null,
         "3.25",
         "4.710000038146973",
         "0.0",
         "0.0",
         null,
         null,
         null,
         null,
         null
        ],
        [
         "ABUS",
         "Arbutus Biopharma Corporation",
         "Healthcare",
         "Biotechnology",
         "Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States. Its chronic Hepatitis B virus product pipeline comprises Imdusiran, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic product candidate which is in phase 1 and phase 2a clinical trials that suppresses all HBV antigens, including HBsAg expression; and AB-101, an oral PD-L1 inhibitor, which is in phase 1a/1b clinical trial that has the potential to reawaken patients' HBV-specific immune response by inhibiting PD-L1. The company has licensing agreement with Alnylam Pharmaceuticals, Inc. to develop and commercialize products with LNP delivery technology. The company was formerly known as Tekmira Pharmaceuticals Corporation and changed its name to Arbutus Biopharma Corporation in July 2015. Arbutus Biopharma Corporation was incorporated in 2005 is headquartered in Warminster, Pennsylvania.",
         "EQUITY",
         "2024-12-31",
         "191527008.0",
         "599479552.0",
         "484709824.0",
         null,
         "-9.205883",
         "-0.41",
         "-0.34",
         null,
         "1.243",
         "3.130000114440918",
         "-0.43",
         "-0.3745",
         "0.16725531483047873",
         null,
         null,
         null,
         null
        ],
        [
         "ABVC",
         "ABVC BioPharma, Inc.",
         "Healthcare",
         "Biotechnology",
         "ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials as a combination therapy for triple negative breast cancer; ABV-1504, which has completed Phase II clinical trials for depressive disorders; ABV-1505, which is in Phase II clinical trials for adult attention deficit hyperactivity disorder; ABV-1702, which is in Phase II clinical trials to treat myelodysplastic syndromes; and ABV-1601, which is in Phase I/II clinical trials for treating depression in cancer patients. It is also developing ABV-1701 Vitargus, which is in Phase II clinical trials for the treatment of retinal detachment or vitreous hemorrhage; and ABV-1519, which is in Phase I/II clinical trials for the treatment of non-small cell lung cancer; ABV-1703, which is in Phase II clinical trials for the treatment of metastatic pancreatic cancer. ABVC BioPharma, Inc. has a co-development agreement with Rgene Corporation and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is headquartered in Fremont, California. ABVC BioPharma, Inc. operates as a subsidiary of YuanGene Corporation.",
         "EQUITY",
         "2024-12-31",
         "16981600.0",
         "56888360.0",
         "40910892.0",
         null,
         "-7.613636",
         "-0.19",
         "-0.44",
         null,
         "0.186",
         "3.3499999046325684",
         "0.0",
         "0.0",
         null,
         null,
         null,
         null,
         null
        ],
        [
         "ABVE",
         "Above Food Ingredients Inc.",
         "Consumer Defensive",
         "Packaged Foods",
         "Above Food Ingredients Inc., a regenerative ingredient company, produces vertically integrated supply chain products in Canada, the United States, Mexico, China, France, Turkey, and internationally. It operates through two segments: Disruptive Agriculture and Rudimentary Ingredients, and Consumer Packaged Goods. The Disruptive Agriculture and Rudimentary Ingredients segment engages in the provisioning of discrete genetics, origination, purchasing, grading, processing, and sale of regeneratively grown grain; and origination, purchase, and sale of bespoke ingredients products. The Consumer Packaged Goods segment formulates, manufactures, sells, distributes, and markets proprietary consumer product formulations in owned brands; and focuses on manufacturing and distribution for private-labeled retail owned brands. Above Food Ingredients Inc. is based in Regina, Canada.",
         "EQUITY",
         "2024-01-31",
         "51191800.0",
         "138217856.0",
         "165132080.0",
         null,
         null,
         "-1.76",
         null,
         null,
         "-0.283",
         "2.700000047683716",
         "0.0",
         "0.0",
         null,
         null,
         null,
         null,
         null
        ],
        [
         "ABVEW",
         "Above Food Ingredients Inc.",
         "Consumer Defensive",
         "Packaged Foods",
         "Above Food Ingredients Inc., a regenerative ingredient company, produces vertically integrated supply chain products in Canada, the United States, Mexico, China, France, Turkey, and internationally. It operates through two segments: Disruptive Agriculture and Rudimentary Ingredients, and Consumer Packaged Goods. The Disruptive Agriculture and Rudimentary Ingredients segment engages in the provisioning of discrete genetics, origination, purchasing, grading, processing, and sale of regeneratively grown grain; and origination, purchase, and sale of bespoke ingredients products. The Consumer Packaged Goods segment formulates, manufactures, sells, distributes, and markets proprietary consumer product formulations in owned brands; and focuses on manufacturing and distribution for private-labeled retail owned brands. Above Food Ingredients Inc. is based in Regina, Canada.",
         "EQUITY",
         "2024-12-31",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "-0.283",
         "0.2750000059604645",
         "0.0",
         "0.0",
         null,
         null,
         null,
         null,
         null
        ],
        [
         "ABVX",
         "ABIVAX Société Anonyme",
         "Healthcare",
         "Biotechnology",
         "ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod that is in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis, as well as in Phase 2b clinical trial to treat patients with Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.",
         "EQUITY",
         "2024-12-31",
         "63471900.0",
         "641750144.0",
         "488139424.0",
         null,
         "-3.294702",
         "-3.43",
         "-3.02",
         null,
         "1.509",
         "9.949999809265137",
         "-3.43425",
         "-2.645",
         "0.03133603641102356",
         null,
         null,
         null,
         null
        ],
        [
         "AC",
         "Associated Capital Group, Inc.",
         "Financial Services",
         "Asset Management",
         "Associated Capital Group, Inc., together with its subsidiaries, provides investment advisory services in the United States. It offers alternative investment management services; operates a direct investment business; and invests in new and existing businesses. The company was founded in 1976 and is headquartered in Greenwich, Connecticut. Associated Capital Group, Inc. is a subsidiary of GGCP Holdings LLC.",
         "EQUITY",
         "2024-12-31",
         "2187110.0",
         "787379328.0",
         "440531872.0",
         "20.694445",
         "14.38224",
         "1.8",
         "2.59",
         null,
         "0.606",
         "37.25",
         "0.0",
         "0.0",
         null,
         null,
         null,
         null,
         null
        ],
        [
         "ACA",
         "Arcosa, Inc.",
         "Industrials",
         "Engineering & Construction",
         "Arcosa, Inc., together with its subsidiaries, provides infrastructure-related products and solutions for the construction, engineered structures, and transportation markets in the United States. The company operates through three segments: Construction Products, Engineered Structures, and Transportation Products. The Construction Products segment offers natural and recycled aggregates; specialty materials; and construction site support equipment, including trench shields and shoring products for residential and non-residential construction, and specialty/other products, as well as for infrastructure construction. The Engineered Structures segment offers utility structures, wind towers, traffic and lighting structures, and telecommunication structures for electricity transmission and distribution, wind power generation, highway road construction, and wireless communication markets. This segment sells its products to contractors and distributors serving state Departments of Transportation and state and municipality agencies. The Transportation Products segment offers inland barges, fiberglass barge covers, winches, marine hardware, and other transportation and industrial equipment to the commercial marine transportation companies, lessors, and industrial shippers. Arcosa, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.",
         "EQUITY",
         "2024-12-31",
         "48816100.0",
         "4393448960.0",
         "5813242880.0",
         "56.60377",
         "20.36199",
         "1.59",
         "4.42",
         null,
         "1.005",
         "90.0",
         "3.78133",
         "4.6855",
         "0.2455830401864021",
         "23.801149331055473",
         "19.208195496745276",
         "0.9691690970593881",
         "0.7821466613560082"
        ],
        [
         "ACAD",
         "ACADIA Pharmaceuticals Inc.",
         "Healthcare",
         "Biotechnology",
         "ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis; and DAYBUE, a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 for treatment of Rett Syndrome. It also develops Pimavanserin which completed Phase III clinical trial to treat the negative symptoms of schizophrenia; ACP-101, which completed phase III clinical trial for the treatment of hyperphagia in Prader-Willi syndrome; ACP-204 that completed phase II clinical trial for the treatment of Alzheimer's disease psychosis and Lewy Body Dementia with psychosis; ACP-711, which is in phase I clinical trial for the treatment of essential tremor; ACP-211 that is in phase I clinical trial for the treatment of treatment-resistant depression; ACP-2591 that is in Phase I development for Rett syndrome and Fragile X syndrome; and ACP-271, a GPR88 agonist used in evaluation of neurology and is in the IND-enabling stage. The company has a license agreement with Neuren Pharmaceuticals Limited to trofinetide for Rett syndrome and other indications; and a license and collaboration agreement with Stoke Therapeutics, Inc. to discover, develop and commercialize novel RNA-based medicines for the potential treatment of severe and rare genetic neurodevelopmental diseases of the CNS. The company was formerly known as Receptor Technologies, Inc. and changed its name ACADIA Pharmaceuticals Inc. in 1997. ACADIA Pharmaceuticals Inc. was incorporated in 1993 and is headquartered in San Diego, California.",
         "EQUITY",
         "2024-12-31",
         "167362000.0",
         "3775686656.0",
         "2984424192.0",
         "16.467154",
         "27.512196",
         "1.37",
         "0.82",
         null,
         "0.649",
         "22.559999465942383",
         "0.53076",
         "0.87374",
         "-0.1984316248753324",
         "42.505086038779076",
         "25.820037386341912",
         null,
         null
        ],
        [
         "ACB",
         "Aurora Cannabis Inc.",
         "Healthcare",
         "Drug Manufacturers - Specialty & Generic",
         "Aurora Cannabis Inc., together with its subsidiaries, engages in production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; sale of medical and consumer use cannabis products; and the propagation of vegetables and floral plants. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. The company was founded in 2013 and is headquartered in Edmonton, Canada.",
         "EQUITY",
         "2025-03-31",
         "56246400.0",
         "254796208.0",
         "245961136.0",
         "20.59091",
         "-41.18182",
         "0.22",
         "-0.11",
         null,
         "3.319",
         "4.53000020980835",
         "0.0",
         "0.0",
         null,
         null,
         null,
         null,
         null
        ],
        [
         "ACCO",
         "ACCO Brands Corporation",
         "Industrials",
         "Business Equipment & Supplies",
         "ACCO Brands Corporation designs, manufactures, and markets consumer, school, technology, and office products in the United States, Canada, Brazil, Mexico, Chile, Europe, the Middle East, Australia, New Zealand, and Asia. It operates in two segments, ACCO Brands Americas and ACCO Brands International. The company offers note taking products, computer and gaming accessories, planners, workspace machines, tools and essentials, and dry erase boards and accessories, as well as filing and organization products, and writing and art products; and shredding, laminating and binding machines, stapling, punching, and do-it-yourself tools. It sells its products under the Five Star, PowerA, Tilibra, AT-A-GLANCE, Kensington, Quartet, GBC, Mead, Swingline, Barrilito, Foroni, Hilroy, Leitz, Rapid, Esselte, Rexel, PowerA, NOBO, Franken, Derwent, Marbig, Artline, and Spirax brands. The company distributes its products through various channels, including mass retailers, e-tailers, discount, drug/grocery, and variety chains, warehouse clubs, hardware and specialty stores, independent office product dealers, office superstores, wholesalers, contract stationers, and technology specialty businesses, as well as sells products directly to commercial and consumer end-users through its e-commerce platform and direct sales organization. The company was founded in 1893 and is headquartered in Lake Zurich, Illinois.",
         "EQUITY",
         "2024-12-31",
         "90099104.0",
         "337871648.0",
         "1211254656.0",
         null,
         "3.2608697",
         "-1.13",
         "1.15",
         "0.3571",
         "1.327",
         "3.75",
         "0.94",
         "1.07667",
         "0.027424274581830055",
         "3.9893617021276597",
         "3.4829613530608263",
         "1.4546826718147032",
         "1.2700286174090678"
        ],
        [
         "ACCS",
         "ACCESS Newswire Inc.",
         "Communication Services",
         "Advertising Agencies",
         "ACCESS Newswire Inc. provides solutions for public relations and investor relations in the United States and internationally. The company offers press release and optimizer, media database and pitching, media monitoring, and media room; ACCESSWIRE, a news dissemination and media outreach solution; and Webcaster Platform, a cloud-based webcast, webinar, and virtual meeting platform that delivers live and on-demand streaming of events to audiences of various sizes, as well as allows customers to create, produce, and deliver events. It also offers professional conference and events software, a mobile app that offers one-on-one meetings, as well as manage schedules and lodging, perform event promotion and sponsorship, and print attendee badges; and investor relations content network, a series of data feeds, which include news feeds, stock feeds, fundamentals, regulatory filings, corporate governance, and other components. In addition, the company provides whistleblower hotline, a system that delivers secure notifications and basic incident workflow management processes that align with a company's corporate governance policies. It serves public and private companies. The company was formerly known as Issuer Direct Corporation and changed its name to ACCESS Newswire Inc. in January 2025. ACCESS Newswire Inc. was incorporated in 1988 and is headquartered in Raleigh, North Carolina.",
         "EQUITY",
         "2024-12-31",
         "3847740.0",
         "46249836.0",
         "47396240.0",
         null,
         "13.3555565",
         "-3.46",
         null,
         null,
         "0.811",
         "12.020000457763672",
         "0.43",
         "0.9",
         "1.070175548111802",
         "27.9534894366597",
         "13.355556064181858",
         "0.26120471062883394",
         "0.12479780618933178"
        ],
        [
         "ACDC",
         "ProFrac Holding Corp.",
         "Energy",
         "Oil & Gas Equipment & Services",
         "ProFrac Holding Corp. operates as a technology-focused energy services holding company in the United States. It operates through three segments: Stimulation Services, Proppant Production, and Manufacturing. The company offers hydraulic fracturing, proppant production, well stimulation, in-basin frac sand, and other completion services and complementary products and services to upstream oil and natural gas companies engaged in the exploration and production of unconventional oil and natural gas resources. It also manufactures and sells high horsepower pumps, valves, piping, swivels, large-bore manifold systems, and fluid ends, as well as other auxiliary equipment. The company was founded in 2016 and is headquartered in Willow Park, Texas.",
         "EQUITY",
         "2024-12-31",
         "160178000.0",
         "1270211456.0",
         "2647084544.0",
         null,
         "-33.041668",
         "-1.5",
         "-0.24",
         null,
         "1.754",
         "7.929999828338623",
         "-0.8359",
         "-0.50702",
         "-0.021457996746179542",
         null,
         null,
         null,
         null
        ]
       ],
       "shape": {
        "columns": 23,
        "rows": 6315
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Long Name</th>\n",
       "      <th>Sector</th>\n",
       "      <th>Industry</th>\n",
       "      <th>Long Business Summary</th>\n",
       "      <th>Quote Type</th>\n",
       "      <th>Last Fiscal Year End</th>\n",
       "      <th>Shares Outstanding</th>\n",
       "      <th>Market Cap</th>\n",
       "      <th>Enterprise Value</th>\n",
       "      <th>Trailing Pe</th>\n",
       "      <th>...</th>\n",
       "      <th>Trailing Peg Ratio</th>\n",
       "      <th>Beta</th>\n",
       "      <th>Price</th>\n",
       "      <th>Forward EPS (This Year)</th>\n",
       "      <th>Forward EPS (Next Year)</th>\n",
       "      <th>Forward EPS Growth (CAGR)</th>\n",
       "      <th>Forward PER (This Year)</th>\n",
       "      <th>Forward PER (Next Year)</th>\n",
       "      <th>Forward PEGR (This Year)</th>\n",
       "      <th>Forward PEGR (Next Year)</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Ticker</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>A</th>\n",
       "      <td>Agilent Technologies, Inc.</td>\n",
       "      <td>Healthcare</td>\n",
       "      <td>Diagnostics &amp; Research</td>\n",
       "      <td>Agilent Technologies, Inc. provides applicatio...</td>\n",
       "      <td>EQUITY</td>\n",
       "      <td>2024-10-31</td>\n",
       "      <td>284064992.0</td>\n",
       "      <td>3.305379e+10</td>\n",
       "      <td>3.572048e+10</td>\n",
       "      <td>28.076355</td>\n",
       "      <td>...</td>\n",
       "      <td>1.6741</td>\n",
       "      <td>1.232</td>\n",
       "      <td>113.989998</td>\n",
       "      <td>5.57854</td>\n",
       "      <td>6.06230</td>\n",
       "      <td>0.070479</td>\n",
       "      <td>20.433661</td>\n",
       "      <td>18.803094</td>\n",
       "      <td>2.899258</td>\n",
       "      <td>2.667903</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>AA</th>\n",
       "      <td>Alcoa Corporation</td>\n",
       "      <td>Basic Materials</td>\n",
       "      <td>Aluminum</td>\n",
       "      <td>Alcoa Corporation, together with its subsidiar...</td>\n",
       "      <td>EQUITY</td>\n",
       "      <td>2024-12-31</td>\n",
       "      <td>258902000.0</td>\n",
       "      <td>7.852497e+09</td>\n",
       "      <td>9.234208e+09</td>\n",
       "      <td>18.271084</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2.257</td>\n",
       "      <td>30.330000</td>\n",
       "      <td>3.40869</td>\n",
       "      <td>2.87543</td>\n",
       "      <td>0.459483</td>\n",
       "      <td>8.897846</td>\n",
       "      <td>10.547988</td>\n",
       "      <td>0.193649</td>\n",
       "      <td>0.229562</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>AACB</th>\n",
       "      <td>Artius II Acquisition Inc.</td>\n",
       "      <td>Financial Services</td>\n",
       "      <td>Shell Companies</td>\n",
       "      <td>Artius II Acquisition Inc. does not have signi...</td>\n",
       "      <td>EQUITY</td>\n",
       "      <td>2024-12-31</td>\n",
       "      <td>23650000.0</td>\n",
       "      <td>2.972340e+08</td>\n",
       "      <td>2.971719e+08</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>10.110000</td>\n",
       "      <td>0.00000</td>\n",
       "      <td>0.00000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>AACBU</th>\n",
       "      <td>Artius II Acquisition Inc.</td>\n",
       "      <td>Financial Services</td>\n",
       "      <td>Shell Companies</td>\n",
       "      <td>Artius II Acquisition Inc. does not have signi...</td>\n",
       "      <td>EQUITY</td>\n",
       "      <td>2024-12-31</td>\n",
       "      <td>25175000.0</td>\n",
       "      <td>2.668550e+08</td>\n",
       "      <td>3.083439e+08</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>10.600000</td>\n",
       "      <td>0.00000</td>\n",
       "      <td>0.00000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>AACG</th>\n",
       "      <td>ATA Creativity Global</td>\n",
       "      <td>Consumer Defensive</td>\n",
       "      <td>Education &amp; Training Services</td>\n",
       "      <td>ATA Creativity Global, together with its subsi...</td>\n",
       "      <td>EQUITY</td>\n",
       "      <td>2024-12-31</td>\n",
       "      <td>31624500.0</td>\n",
       "      <td>2.593209e+07</td>\n",
       "      <td>5.638321e+07</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.884</td>\n",
       "      <td>0.820000</td>\n",
       "      <td>0.00000</td>\n",
       "      <td>0.00000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ZVRA</th>\n",
       "      <td>Zevra Therapeutics, Inc.</td>\n",
       "      <td>Healthcare</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Zevra Therapeutics, Inc., a commercial-stage c...</td>\n",
       "      <td>EQUITY</td>\n",
       "      <td>2024-12-31</td>\n",
       "      <td>54679600.0</td>\n",
       "      <td>6.599828e+08</td>\n",
       "      <td>4.809336e+08</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.986</td>\n",
       "      <td>12.070000</td>\n",
       "      <td>1.09143</td>\n",
       "      <td>0.64429</td>\n",
       "      <td>0.209618</td>\n",
       "      <td>11.058886</td>\n",
       "      <td>18.733800</td>\n",
       "      <td>0.527572</td>\n",
       "      <td>0.893710</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ZWS</th>\n",
       "      <td>Zurn Elkay Water Solutions Corporation</td>\n",
       "      <td>Industrials</td>\n",
       "      <td>Pollution &amp; Treatment Controls</td>\n",
       "      <td>Zurn Elkay Water Solutions Corporation engages...</td>\n",
       "      <td>EQUITY</td>\n",
       "      <td>2024-12-31</td>\n",
       "      <td>168252000.0</td>\n",
       "      <td>6.317862e+09</td>\n",
       "      <td>6.565186e+09</td>\n",
       "      <td>39.114582</td>\n",
       "      <td>...</td>\n",
       "      <td>1.7029</td>\n",
       "      <td>0.782</td>\n",
       "      <td>37.549999</td>\n",
       "      <td>1.34108</td>\n",
       "      <td>1.46972</td>\n",
       "      <td>0.071529</td>\n",
       "      <td>27.999820</td>\n",
       "      <td>25.549084</td>\n",
       "      <td>3.914470</td>\n",
       "      <td>3.571849</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ZYBT</th>\n",
       "      <td>Zhengye Biotechnology Holding Limited</td>\n",
       "      <td>Healthcare</td>\n",
       "      <td>Drug Manufacturers - Specialty &amp; Generic</td>\n",
       "      <td>Zhengye Biotechnology Holding Limited engages ...</td>\n",
       "      <td>EQUITY</td>\n",
       "      <td>2023-12-31</td>\n",
       "      <td>47391400.0</td>\n",
       "      <td>2.696571e+08</td>\n",
       "      <td>4.196373e+08</td>\n",
       "      <td>189.666670</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>5.690000</td>\n",
       "      <td>0.00000</td>\n",
       "      <td>0.00000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ZYME</th>\n",
       "      <td>Zymeworks Inc.</td>\n",
       "      <td>Healthcare</td>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>Zymeworks Inc., a clinical-stage biotechnology...</td>\n",
       "      <td>EQUITY</td>\n",
       "      <td>2024-12-31</td>\n",
       "      <td>74844496.0</td>\n",
       "      <td>1.066534e+09</td>\n",
       "      <td>6.277059e+08</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.175</td>\n",
       "      <td>14.250000</td>\n",
       "      <td>-1.57471</td>\n",
       "      <td>-1.34076</td>\n",
       "      <td>0.086628</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ZYXI</th>\n",
       "      <td>Zynex, Inc.</td>\n",
       "      <td>Healthcare</td>\n",
       "      <td>Medical Distribution</td>\n",
       "      <td>Zynex, Inc., together with its subsidiaries, d...</td>\n",
       "      <td>EQUITY</td>\n",
       "      <td>2024-12-31</td>\n",
       "      <td>30238900.0</td>\n",
       "      <td>6.985186e+07</td>\n",
       "      <td>1.272043e+08</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.816</td>\n",
       "      <td>2.310000</td>\n",
       "      <td>-0.74000</td>\n",
       "      <td>-0.51000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>6315 rows × 23 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                     Long Name              Sector  \\\n",
       "Ticker                                                               \n",
       "A                   Agilent Technologies, Inc.          Healthcare   \n",
       "AA                           Alcoa Corporation     Basic Materials   \n",
       "AACB                Artius II Acquisition Inc.  Financial Services   \n",
       "AACBU               Artius II Acquisition Inc.  Financial Services   \n",
       "AACG                     ATA Creativity Global  Consumer Defensive   \n",
       "...                                        ...                 ...   \n",
       "ZVRA                  Zevra Therapeutics, Inc.          Healthcare   \n",
       "ZWS     Zurn Elkay Water Solutions Corporation         Industrials   \n",
       "ZYBT     Zhengye Biotechnology Holding Limited          Healthcare   \n",
       "ZYME                            Zymeworks Inc.          Healthcare   \n",
       "ZYXI                               Zynex, Inc.          Healthcare   \n",
       "\n",
       "                                        Industry  \\\n",
       "Ticker                                             \n",
       "A                         Diagnostics & Research   \n",
       "AA                                      Aluminum   \n",
       "AACB                             Shell Companies   \n",
       "AACBU                            Shell Companies   \n",
       "AACG               Education & Training Services   \n",
       "...                                          ...   \n",
       "ZVRA                               Biotechnology   \n",
       "ZWS               Pollution & Treatment Controls   \n",
       "ZYBT    Drug Manufacturers - Specialty & Generic   \n",
       "ZYME                               Biotechnology   \n",
       "ZYXI                        Medical Distribution   \n",
       "\n",
       "                                    Long Business Summary Quote Type  \\\n",
       "Ticker                                                                 \n",
       "A       Agilent Technologies, Inc. provides applicatio...     EQUITY   \n",
       "AA      Alcoa Corporation, together with its subsidiar...     EQUITY   \n",
       "AACB    Artius II Acquisition Inc. does not have signi...     EQUITY   \n",
       "AACBU   Artius II Acquisition Inc. does not have signi...     EQUITY   \n",
       "AACG    ATA Creativity Global, together with its subsi...     EQUITY   \n",
       "...                                                   ...        ...   \n",
       "ZVRA    Zevra Therapeutics, Inc., a commercial-stage c...     EQUITY   \n",
       "ZWS     Zurn Elkay Water Solutions Corporation engages...     EQUITY   \n",
       "ZYBT    Zhengye Biotechnology Holding Limited engages ...     EQUITY   \n",
       "ZYME    Zymeworks Inc., a clinical-stage biotechnology...     EQUITY   \n",
       "ZYXI    Zynex, Inc., together with its subsidiaries, d...     EQUITY   \n",
       "\n",
       "       Last Fiscal Year End  Shares Outstanding    Market Cap  \\\n",
       "Ticker                                                          \n",
       "A                2024-10-31         284064992.0  3.305379e+10   \n",
       "AA               2024-12-31         258902000.0  7.852497e+09   \n",
       "AACB             2024-12-31          23650000.0  2.972340e+08   \n",
       "AACBU            2024-12-31          25175000.0  2.668550e+08   \n",
       "AACG             2024-12-31          31624500.0  2.593209e+07   \n",
       "...                     ...                 ...           ...   \n",
       "ZVRA             2024-12-31          54679600.0  6.599828e+08   \n",
       "ZWS              2024-12-31         168252000.0  6.317862e+09   \n",
       "ZYBT             2023-12-31          47391400.0  2.696571e+08   \n",
       "ZYME             2024-12-31          74844496.0  1.066534e+09   \n",
       "ZYXI             2024-12-31          30238900.0  6.985186e+07   \n",
       "\n",
       "        Enterprise Value  Trailing Pe  ...  Trailing Peg Ratio   Beta  \\\n",
       "Ticker                                 ...                              \n",
       "A           3.572048e+10    28.076355  ...              1.6741  1.232   \n",
       "AA          9.234208e+09    18.271084  ...                 NaN  2.257   \n",
       "AACB        2.971719e+08          NaN  ...                 NaN    NaN   \n",
       "AACBU       3.083439e+08          NaN  ...                 NaN    NaN   \n",
       "AACG        5.638321e+07          NaN  ...                 NaN  0.884   \n",
       "...                  ...          ...  ...                 ...    ...   \n",
       "ZVRA        4.809336e+08          NaN  ...                 NaN  1.986   \n",
       "ZWS         6.565186e+09    39.114582  ...              1.7029  0.782   \n",
       "ZYBT        4.196373e+08   189.666670  ...                 NaN    NaN   \n",
       "ZYME        6.277059e+08          NaN  ...                 NaN  1.175   \n",
       "ZYXI        1.272043e+08          NaN  ...                 NaN  0.816   \n",
       "\n",
       "             Price  Forward EPS (This Year)  Forward EPS (Next Year)  \\\n",
       "Ticker                                                                 \n",
       "A       113.989998                  5.57854                  6.06230   \n",
       "AA       30.330000                  3.40869                  2.87543   \n",
       "AACB     10.110000                  0.00000                  0.00000   \n",
       "AACBU    10.600000                  0.00000                  0.00000   \n",
       "AACG      0.820000                  0.00000                  0.00000   \n",
       "...            ...                      ...                      ...   \n",
       "ZVRA     12.070000                  1.09143                  0.64429   \n",
       "ZWS      37.549999                  1.34108                  1.46972   \n",
       "ZYBT      5.690000                  0.00000                  0.00000   \n",
       "ZYME     14.250000                 -1.57471                 -1.34076   \n",
       "ZYXI      2.310000                 -0.74000                 -0.51000   \n",
       "\n",
       "        Forward EPS Growth (CAGR)  Forward PER (This Year)  \\\n",
       "Ticker                                                       \n",
       "A                        0.070479                20.433661   \n",
       "AA                       0.459483                 8.897846   \n",
       "AACB                          NaN                      NaN   \n",
       "AACBU                         NaN                      NaN   \n",
       "AACG                          NaN                      NaN   \n",
       "...                           ...                      ...   \n",
       "ZVRA                     0.209618                11.058886   \n",
       "ZWS                      0.071529                27.999820   \n",
       "ZYBT                          NaN                      NaN   \n",
       "ZYME                     0.086628                      NaN   \n",
       "ZYXI                          NaN                      NaN   \n",
       "\n",
       "        Forward PER (Next Year)  Forward PEGR (This Year)  \\\n",
       "Ticker                                                      \n",
       "A                     18.803094                  2.899258   \n",
       "AA                    10.547988                  0.193649   \n",
       "AACB                        NaN                       NaN   \n",
       "AACBU                       NaN                       NaN   \n",
       "AACG                        NaN                       NaN   \n",
       "...                         ...                       ...   \n",
       "ZVRA                  18.733800                  0.527572   \n",
       "ZWS                   25.549084                  3.914470   \n",
       "ZYBT                        NaN                       NaN   \n",
       "ZYME                        NaN                       NaN   \n",
       "ZYXI                        NaN                       NaN   \n",
       "\n",
       "        Forward PEGR (Next Year)  \n",
       "Ticker                            \n",
       "A                       2.667903  \n",
       "AA                      0.229562  \n",
       "AACB                         NaN  \n",
       "AACBU                        NaN  \n",
       "AACG                         NaN  \n",
       "...                          ...  \n",
       "ZVRA                    0.893710  \n",
       "ZWS                     3.571849  \n",
       "ZYBT                         NaN  \n",
       "ZYME                         NaN  \n",
       "ZYXI                         NaN  \n",
       "\n",
       "[6315 rows x 23 columns]"
      ]
     },
     "execution_count": 101,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "db.stocks_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 93,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "Ticker",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "Long Name",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "Sector",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "Industry",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "Long Business Summary",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "Quote Type",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "Last Fiscal Year End",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "Shares Outstanding",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "Market Cap",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "Enterprise Value",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "Trailing Pe",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "Forward Pe",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "Trailing Eps",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "Forward Eps",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "Trailing Peg Ratio",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "Beta",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "Price",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "Forward EPS (This Year)",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "Forward EPS (Next Year)",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "Forward EPS Growth (CAGR)",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "Forward PER (This Year)",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "Forward PER (Next Year)",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "Forward PEGR (This Year)",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "Forward PEGR (Next Year)",
         "rawType": "float64",
         "type": "float"
        }
       ],
       "ref": "7c7223eb-3c9c-46c3-9eb9-b0831ca14233",
       "rows": [
        [
         "AACG",
         "ATA Creativity Global",
         "Consumer Defensive",
         "Education & Training Services",
         "ATA Creativity Global, together with its subsidiaries, provides educational services in China and internationally. The company offers portfolio training services, research-based learning services, overseas study counselling services, in-school art classes through cooperation with high schools and training organizations, junior art education, and other educational services to students. It also provides online courses for students. The company provides its services through partnership with sales channels, internet and mobile advertisement, word of mouth referral, and marketing events and activities. The company was formerly known as ATA Inc. and changed its name to ATA Creativity Global in September 2019. ATA Creativity Global was founded in 1999 and is based in Hefei, China.",
         "EQUITY",
         "2024-12-31",
         "31624500.0",
         "25932090.0",
         "56383208.0",
         null,
         "-0.82828283",
         "-0.14",
         "-0.99",
         null,
         "0.884",
         "0.8199999928474426",
         "0.0",
         "0.0",
         null,
         null,
         null,
         null,
         null
        ]
       ],
       "shape": {
        "columns": 23,
        "rows": 1
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Long Name</th>\n",
       "      <th>Sector</th>\n",
       "      <th>Industry</th>\n",
       "      <th>Long Business Summary</th>\n",
       "      <th>Quote Type</th>\n",
       "      <th>Last Fiscal Year End</th>\n",
       "      <th>Shares Outstanding</th>\n",
       "      <th>Market Cap</th>\n",
       "      <th>Enterprise Value</th>\n",
       "      <th>Trailing Pe</th>\n",
       "      <th>...</th>\n",
       "      <th>Trailing Peg Ratio</th>\n",
       "      <th>Beta</th>\n",
       "      <th>Price</th>\n",
       "      <th>Forward EPS (This Year)</th>\n",
       "      <th>Forward EPS (Next Year)</th>\n",
       "      <th>Forward EPS Growth (CAGR)</th>\n",
       "      <th>Forward PER (This Year)</th>\n",
       "      <th>Forward PER (Next Year)</th>\n",
       "      <th>Forward PEGR (This Year)</th>\n",
       "      <th>Forward PEGR (Next Year)</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Ticker</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>AACG</th>\n",
       "      <td>ATA Creativity Global</td>\n",
       "      <td>Consumer Defensive</td>\n",
       "      <td>Education &amp; Training Services</td>\n",
       "      <td>ATA Creativity Global, together with its subsi...</td>\n",
       "      <td>EQUITY</td>\n",
       "      <td>2024-12-31</td>\n",
       "      <td>31624500.0</td>\n",
       "      <td>25932090.0</td>\n",
       "      <td>56383208.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.884</td>\n",
       "      <td>0.82</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1 rows × 23 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                    Long Name              Sector  \\\n",
       "Ticker                                              \n",
       "AACG    ATA Creativity Global  Consumer Defensive   \n",
       "\n",
       "                             Industry  \\\n",
       "Ticker                                  \n",
       "AACG    Education & Training Services   \n",
       "\n",
       "                                    Long Business Summary Quote Type  \\\n",
       "Ticker                                                                 \n",
       "AACG    ATA Creativity Global, together with its subsi...     EQUITY   \n",
       "\n",
       "       Last Fiscal Year End  Shares Outstanding  Market Cap  Enterprise Value  \\\n",
       "Ticker                                                                          \n",
       "AACG             2024-12-31          31624500.0  25932090.0        56383208.0   \n",
       "\n",
       "        Trailing Pe  ...  Trailing Peg Ratio   Beta  Price  \\\n",
       "Ticker               ...                                     \n",
       "AACG            NaN  ...                 NaN  0.884   0.82   \n",
       "\n",
       "        Forward EPS (This Year)  Forward EPS (Next Year)  \\\n",
       "Ticker                                                     \n",
       "AACG                        0.0                      0.0   \n",
       "\n",
       "        Forward EPS Growth (CAGR)  Forward PER (This Year)  \\\n",
       "Ticker                                                       \n",
       "AACG                          NaN                      NaN   \n",
       "\n",
       "        Forward PER (Next Year)  Forward PEGR (This Year)  \\\n",
       "Ticker                                                      \n",
       "AACG                        NaN                       NaN   \n",
       "\n",
       "        Forward PEGR (Next Year)  \n",
       "Ticker                            \n",
       "AACG                         NaN  \n",
       "\n",
       "[1 rows x 23 columns]"
      ]
     },
     "execution_count": 93,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "db.stocks_df.loc[[\"AACG\"]]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "dev3.12",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.9"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
